<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Pathog</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Pathog</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plospath</journal-id><journal-title-group><journal-title>PLoS Pathogens</journal-title></journal-title-group><issn pub-type="ppub">1553-7366</issn><issn pub-type="epub">1553-7374</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4970705</article-id><article-id pub-id-type="doi">10.1371/journal.ppat.1005803</article-id><article-id pub-id-type="publisher-id">PPATHOGENS-D-16-00215</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune System Proteins</subject><subj-group><subject>Inflammasomes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune System Proteins</subject><subj-group><subject>Inflammasomes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Immune System Proteins</subject><subj-group><subject>Inflammasomes</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Cell Biology</subject><subj-group><subject>Cellular Types</subject><subj-group><subject>Animal Cells</subject><subj-group><subject>Blood Cells</subject><subj-group><subject>White Blood Cells</subject><subj-group><subject>Macrophages</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Cell Biology</subject><subj-group><subject>Cellular Types</subject><subj-group><subject>Animal Cells</subject><subj-group><subject>Immune Cells</subject><subj-group><subject>White Blood Cells</subject><subj-group><subject>Macrophages</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Cells</subject><subj-group><subject>White Blood Cells</subject><subj-group><subject>Macrophages</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune Cells</subject><subj-group><subject>White Blood Cells</subject><subj-group><subject>Macrophages</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Immunologic Techniques</subject><subj-group><subject>Immunoassays</subject><subj-group><subject>Enzyme-Linked Immunoassays</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Biological Cultures</subject><subj-group><subject>Cell Cultures</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Bacterial Diseases</subject><subj-group><subject>Salmonella</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Bacterial Pathogens</subject><subj-group><subject>Salmonella</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Bacterial Pathogens</subject><subj-group><subject>Salmonella</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Bacteria</subject><subj-group><subject>Enterobacteriaceae</subject><subj-group><subject>Salmonella</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Bacterial Diseases</subject><subj-group><subject>Salmonellosis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Molecular Biology</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Molecular Probe Techniques</subject><subj-group><subject>Immunoblotting</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Molecular Probe Techniques</subject><subj-group><subject>Immunoblotting</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological Processes</subject><subj-group><subject>Secretion</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological Processes</subject><subj-group><subject>Secretion</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>The Prostaglandin E<sub>2</sub>-EP3 Receptor Axis Regulates <italic>Anaplasma phagocytophilum</italic>-Mediated NLRC4 Inflammasome Activation</article-title><alt-title alt-title-type="running-head"><italic>Anaplasma phagocytophilum</italic> Infection and NLRC4 Inflammasome Activation</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Xiaowei</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Shaw</surname><given-names>Dana K.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hammond</surname><given-names>Holly L.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Sutterwala</surname><given-names>Fayyaz S.</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rayamajhi</surname><given-names>Manira</given-names></name><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Shirey</surname><given-names>Kari Ann</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Perkins</surname><given-names>Darren J.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Bonventre</surname><given-names>Joseph V.</given-names></name><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Velayutham</surname><given-names>Thangam S.</given-names></name><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Evans</surname><given-names>Sean M.</given-names></name><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Rodino</surname><given-names>Kyle G.</given-names></name><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>VieBrock</surname><given-names>Lauren</given-names></name><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Scanlon</surname><given-names>Karen M.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Carbonetti</surname><given-names>Nicholas H.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Carlyon</surname><given-names>Jason A.</given-names></name><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Miao</surname><given-names>Edward A.</given-names></name><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>McBride</surname><given-names>Jere W.</given-names></name><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kotsyfakis</surname><given-names>Michail</given-names></name><xref ref-type="aff" rid="aff007"><sup>7</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-8740-2667</contrib-id><name><surname>Pedra</surname><given-names>Joao H. F.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label><addr-line>Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America</addr-line></aff><aff id="aff002"><label>2</label><addr-line>Division of Infectious Diseases, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, United States of America</addr-line></aff><aff id="aff003"><label>3</label><addr-line>Department of Microbiology and Immunology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America</addr-line></aff><aff id="aff004"><label>4</label><addr-line>Renal Division, Brigham and Women&#x02019;s Hospital, Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States of America</addr-line></aff><aff id="aff005"><label>5</label><addr-line>Department of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America</addr-line></aff><aff id="aff006"><label>6</label><addr-line>Department of Microbiology and Immunology, Virginia Commonwealth University School of Medicine, Richmond, Virginia, United States of America</addr-line></aff><aff id="aff007"><label>7</label><addr-line>Institute of Parasitology, Biology Centre, Czech Academy of Sciences, Budweis, Czech Republic</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Zamboni</surname><given-names>Dario S.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>University of S&#x000e3;o Paulo FMRP/USP, BRAZIL</addr-line></aff><author-notes><fn fn-type="conflict" id="coi001"><p>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con" id="contrib001"><p>Conceived and designed the experiments: JHFP XW. Performed the experiments: XW DKS HLH MR TSV LV SME KGR KMS. Analyzed the data: JHFP XW DKS MK. Contributed reagents/materials/analysis tools: FSS NHC JAC KAS DJP JWM EAM JVB MK. Wrote the paper: JHFP XW.</p></fn><corresp id="cor001">* E-mail: <email>jpedra@som.umaryland.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>2</day><month>8</month><year>2016</year></pub-date><pub-date pub-type="collection"><month>8</month><year>2016</year></pub-date><volume>12</volume><issue>8</issue><elocation-id>e1005803</elocation-id><history><date date-type="received"><day>27</day><month>1</month><year>2016</year></date><date date-type="accepted"><day>11</day><month>7</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; 2016 Wang et al</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Wang et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="ppat.1005803.pdf"/><abstract><p>Rickettsial agents are sensed by pattern recognition receptors but lack pathogen-associated molecular patterns commonly observed in facultative intracellular bacteria. Due to these molecular features, the order <italic>Rickettsiales</italic> can be used to uncover broader principles of bacterial immunity. Here, we used the bacterium <italic>Anaplasma phagocytophilum</italic>, the agent of human granulocytic anaplasmosis, to reveal a novel microbial surveillance system. Mechanistically, we discovered that upon <italic>A</italic>. <italic>phagocytophilum</italic> infection, cytosolic phospholipase A<sub>2</sub> cleaves arachidonic acid from phospholipids, which is converted to the eicosanoid prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) via cyclooxygenase 2 (COX2) and the membrane associated prostaglandin E synthase-1 (mPGES-1). PGE<sub>2</sub>-EP3 receptor signaling leads to activation of the NLRC4 inflammasome and secretion of interleukin (IL)-1&#x003b2; and IL-18. Importantly, the receptor-interacting serine/threonine-protein kinase 2 (RIPK2) was identified as a major regulator of the immune response against <italic>A</italic>. <italic>phagocytophilum</italic>. Accordingly, mice lacking COX2 were more susceptible to <italic>A</italic>. <italic>phagocytophilum</italic>, had a defect in IL-18 secretion and exhibited splenomegaly and damage to the splenic architecture. Remarkably, <italic>Salmonella</italic>-induced NLRC4 inflammasome activation was not affected by either chemical inhibition or genetic ablation of genes associated with PGE<sub>2</sub> biosynthesis and signaling. This divergence in immune circuitry was due to reduced levels of the PGE<sub>2</sub>-EP3 receptor during <italic>Salmonella</italic> infection when compared to <italic>A</italic>. <italic>phagocytophilum</italic>. Collectively, we reveal the existence of a functionally distinct NLRC4 inflammasome illustrated by the rickettsial agent <italic>A</italic>. <italic>phagocytophilum</italic>.</p></abstract><abstract abstract-type="summary"><title>Author Summary</title><p>Elimination of bacteria is orchestrated by the immune system. Intracellular bacteria are generally recognized by cytosolic molecules named Nod-like receptors (NLRs). One such protein scaffold that senses needle-like structures and globular proteins, namely, the bacterial type III secretion (T3SS) and flagellin, is the NLRC4 inflammasome. The NLRC4 inflammasome induces caspase-1 autoproteolysis and secretion of the pro-inflammatory cytokines interleukin (IL)-1&#x003b2; and IL-18. Here, we show that the obligate intracellular rickettsial pathogen <italic>Anaplasma phagocytophilum</italic>, which does not have a T3SS or flagellin-coding genes, induces a distinct NLRC4 inflammasome circuitry through the eicosanoid prostaglandin E<sub>2</sub> and the EP3 receptor. Conceptually, these findings establish the existence of a distinct microbial surveillance system where the NLRC4 inflammasome senses an obligate intracellular pathogen of public health relevance. Therefore, we propose that rickettsial agents can be used to uncover broader principles of immune surveillance given their unique life style to survive inside the mammalian host and lack of pathogen associated molecular patterns commonly present in most facultative intracellular bacteria.</p></abstract><funding-group><award-group id="award001"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000060</institution-id><institution>National Institute of Allergy and Infectious Diseases</institution></institution-wrap></funding-source><award-id>R01 AI093653</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-8740-2667</contrib-id><name><surname>Pedra</surname><given-names>Joao H.F.</given-names></name></principal-award-recipient></award-group><funding-statement>This work was supported with funds from the National Institutes of Allergy and Infectious Diseases/National Institutes of Health grant (R01 AI093653 to JHFP) <ext-link ext-link-type="uri" xlink:href="http://www.nih.gov">www.nih.gov</ext-link>. This content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="10"/><table-count count="0"/><page-count count="23"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>High-throughput sequencing data have been deposited at the Gene Expression Omnibus database (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo">www.ncbi.nlm.nih.gov/geo</ext-link>) from the National Center for Biotechnology Information (GSE63647).</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>High-throughput sequencing data have been deposited at the Gene Expression Omnibus database (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo">www.ncbi.nlm.nih.gov/geo</ext-link>) from the National Center for Biotechnology Information (GSE63647).</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>Rickettsial diseases are arthropod-borne illnesses caused by obligate intracellular bacteria grouped in the order <italic>Rickettsiales</italic> [<xref rid="ppat.1005803.ref001" ref-type="bibr">1</xref>, <xref rid="ppat.1005803.ref002" ref-type="bibr">2</xref>]. They include: (<italic>i</italic>) rickettsioses due to bacteria of the genus <italic>Rickettsia</italic>, including the spotted fever and the typhus group; (<italic>ii</italic>) scrub typhus due to <italic>Orientia tsutsugamushi;</italic> and (<italic>iii</italic>) ehrlichioses and anaplasmosis due to bacteria within the family Anaplasmataceae [<xref rid="ppat.1005803.ref001" ref-type="bibr">1</xref>, <xref rid="ppat.1005803.ref002" ref-type="bibr">2</xref>]. Some aspects of rickettsial recognition by the immune system have been described [<xref rid="ppat.1005803.ref001" ref-type="bibr">1</xref>, <xref rid="ppat.1005803.ref002" ref-type="bibr">2</xref>]. For instance, <italic>Rickettsia</italic> spp. have a structurally distinct form of lipopolysaccharide (LPS) that appears identifiable by Toll-like receptor (TLR)4 [<xref rid="ppat.1005803.ref002" ref-type="bibr">2</xref>&#x02013;<xref rid="ppat.1005803.ref005" ref-type="bibr">5</xref>], whereas the TLR2-MyD88 (Myeloid Differentiation Primary Response Protein 88) axis plays a critical role in host defense against ehrlichial infection [<xref rid="ppat.1005803.ref006" ref-type="bibr">6</xref>, <xref rid="ppat.1005803.ref007" ref-type="bibr">7</xref>]. However, how these organisms are sensed by pattern recognition receptors (PRRs) remains mostly undefined. <italic>Bona fide</italic> pathogen-associated molecular patterns (PAMPs) are conspicuously absent in some of these microbes when compared to classically-defined bacterial pathogens [<xref rid="ppat.1005803.ref002" ref-type="bibr">2</xref>, <xref rid="ppat.1005803.ref008" ref-type="bibr">8</xref>&#x02013;<xref rid="ppat.1005803.ref010" ref-type="bibr">10</xref>]. As an example, <italic>Anaplasma</italic> and <italic>Ehrlichia</italic> spp. are considered Gram-negative bacteria, but are unable to synthesize LPS or peptidoglycans [<xref rid="ppat.1005803.ref008" ref-type="bibr">8</xref>, <xref rid="ppat.1005803.ref009" ref-type="bibr">9</xref>, <xref rid="ppat.1005803.ref011" ref-type="bibr">11</xref>]. Additionally, <italic>O</italic>. <italic>tsutsugamushi</italic> does not carry genes in its genome for producing lipid A and has no LPS [<xref rid="ppat.1005803.ref010" ref-type="bibr">10</xref>, <xref rid="ppat.1005803.ref012" ref-type="bibr">12</xref>].</p><p>Counterintuitively, three independent groups have demonstrated that the NOD (Nucleotide-Binding Oligomerization Domain Protein)-RIPK2 (Receptor-Interacting Serine/Threonine-Protein Kinase 2) pathway, which recognizes peptidoglycans [<xref rid="ppat.1005803.ref013" ref-type="bibr">13</xref>], were important to combat <italic>Ehrlichia</italic>, <italic>Anaplasma</italic> and <italic>Orientia</italic> spp. infection [<xref rid="ppat.1005803.ref006" ref-type="bibr">6</xref>, <xref rid="ppat.1005803.ref014" ref-type="bibr">14</xref>, <xref rid="ppat.1005803.ref015" ref-type="bibr">15</xref>]. Furthermore, the non-canonical caspase-11 inflammasome, the molecular scaffold that senses LPS in the cytosol and regulates inflammatory cell death or pyroptosis [<xref rid="ppat.1005803.ref016" ref-type="bibr">16</xref>], was shown to mediate <italic>Ehrlichia</italic>-induced immunopathology [<xref rid="ppat.1005803.ref017" ref-type="bibr">17</xref>]. Nonetheless, <italic>Ehrlichia</italic> spp. do not carry genes for the biosynthesis of LPS in their genomes [<xref rid="ppat.1005803.ref011" ref-type="bibr">11</xref>], and are neither cytosolic bacteria nor do they trigger pyroptosis [<xref rid="ppat.1005803.ref008" ref-type="bibr">8</xref>]. Mice deficient in NLRC4 [NOD-like receptor (NLR) containing a caspase activating and recruitment domain (CARD) 4], the adaptor molecule that is engaged by NAIP (Neuronal apoptosis inhibitory protein) receptors upon recognition of the bacterial type III secretion system (T3SS) and flagellin [<xref rid="ppat.1005803.ref018" ref-type="bibr">18</xref>&#x02013;<xref rid="ppat.1005803.ref024" ref-type="bibr">24</xref>], are also susceptible to <italic>A</italic>. <italic>phagocytophilum</italic> [<xref rid="ppat.1005803.ref025" ref-type="bibr">25</xref>]. Importantly, <italic>A</italic>. <italic>phagocytophilum</italic> is aflagellated and does not have a T3SS [<xref rid="ppat.1005803.ref009" ref-type="bibr">9</xref>, <xref rid="ppat.1005803.ref026" ref-type="bibr">26</xref>].</p><p>These findings suggest that the life style of rickettsial agents induces a mode of immune recognition, which can be exploited for the discovery of unique pathogen-sensing systems. Previously, we discovered that mice deficient in <italic>Nlrc4</italic> and <italic>Caspase-1/11</italic> are susceptible to <italic>A</italic>. <italic>phagocytophilum</italic> infection [<xref rid="ppat.1005803.ref025" ref-type="bibr">25</xref>]. We also reported that <italic>A</italic>. <italic>phagocytophilum</italic> causes NLRC4 inflammasome activation and caspase-1 autoproteolysis through the phospholipid-binding protein Annexin A2 [<xref rid="ppat.1005803.ref027" ref-type="bibr">27</xref>, <xref rid="ppat.1005803.ref028" ref-type="bibr">28</xref>]. The mechanistic delineation of how the NLRC4 inflammasome was induced remained elusive. In this article, we show a novel mode of NLRC4 inflammasome circuitry that is dependent on the eicosanoid prostaglandin E<sub>2</sub> (PGE<sub>2</sub>). Upon <italic>A</italic>. <italic>phagocytophilum</italic> infection, cytosolic phospholipase A<sub>2</sub> (cPLA<sub>2</sub>) cleaves arachidonic acid from phospholipids, which is converted to PGE<sub>2</sub> via cyclooxygenase 2 (COX2) and membrane associated prostaglandin E synthase-1 (mPGES-1), the terminal enzyme that catalyzes the isomerization of prostaglandin H<sub>2</sub> (PGH<sub>2</sub>) to PGE<sub>2</sub> [<xref rid="ppat.1005803.ref029" ref-type="bibr">29</xref>, <xref rid="ppat.1005803.ref030" ref-type="bibr">30</xref>]. PGE<sub>2</sub>-EP3 receptor signaling then leads to NLRC4 inflammasome assembly, which induces the release of IL-1&#x003b2; and IL-18. Consistent with our previous reports where mice deficient in RIPK2 are susceptible to <italic>A</italic>. <italic>phagocytophilum</italic> infection [<xref rid="ppat.1005803.ref014" ref-type="bibr">14</xref>], we identified RIPK2 as a major regulator of the innate immune response against <italic>A</italic>. <italic>phagocytophilum</italic>. <italic>Ripk2</italic><sup><italic>-/-</italic></sup> immune cells exhibited a defect in activation for the nuclear factor (NF)-&#x003ba;B and the NLRC4 inflammasome pathways. Altogether, we define the existence of a functionally distinct NLRC4 inflammasome upon microbial infection.</p></sec><sec sec-type="results" id="sec002"><title>Results</title><sec id="sec003"><title><italic>A</italic>. <italic>phagocytophilum</italic> infection stimulates eicosanoid biosynthesis</title><p><italic>A</italic>. <italic>phagocytophilum</italic> transiently infects bone-marrow derived macrophages (BMDMs) [<xref rid="ppat.1005803.ref027" ref-type="bibr">27</xref>, <xref rid="ppat.1005803.ref028" ref-type="bibr">28</xref>] and clinical features in animal models and infected patients suggest classical macrophage activation [<xref rid="ppat.1005803.ref031" ref-type="bibr">31</xref>&#x02013;<xref rid="ppat.1005803.ref034" ref-type="bibr">34</xref>]. To determine which genes are important for host immunity, we infected macrophages with <italic>A</italic>. <italic>phagocytophilum</italic>. Deep sequencing analysis [deposited at the Gene Expression Omnibus database (GSE63647)] indicated that the transcription of genes that encode for phospholipase A<sub>2</sub> (<italic>pla2g12a</italic>, <italic>pla2g5 and pla2g2e</italic>), COX2 (<italic>ptgs2</italic>) and PGE synthase (<italic>ptges</italic>) was increased upon <italic>A</italic>. <italic>phagocytophilum</italic> infection (<xref ref-type="fig" rid="ppat.1005803.g001">Fig 1A</xref>). These genes are critical for prostanoid biosynthesis (<xref ref-type="fig" rid="ppat.1005803.g001">Fig 1B</xref>) [<xref rid="ppat.1005803.ref035" ref-type="bibr">35</xref>] and correlated with elevated enzymatic activities of cytosolic phospholipase A<sub>2</sub> (cPLA<sub>2</sub>), COX1 and COX2 (<xref ref-type="fig" rid="ppat.1005803.g001">Fig 1C&#x02013;1E</xref>), which led to increased levels of arachidonic acid (AA), PGE<sub>2</sub>, prostaglandin D<sub>2</sub> (PGD<sub>2</sub>) and thromboxane A<sub>2</sub> (TBXA<sub>2</sub>) (<xref ref-type="fig" rid="ppat.1005803.g001">Fig 1F&#x02013;1I</xref>) upon <italic>A</italic>. <italic>phagocytophilum</italic> infection.</p><fig id="ppat.1005803.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1005803.g001</object-id><label>Fig 1</label><caption><title>A. phagocytophilum infection induces eicosanoid biosynthesis.</title><p>(A) Heat map of deep sequencing analysis showing the expression of eicosanoid metabolism genes in murine BMDMs (1.5&#x000d7;10<sup>7</sup> cells) infected with <italic>A</italic>. <italic>phagocytophilum</italic> (MOI50) for 18 hours. (B) Schematics of eicosanoid metabolism in murine macrophages. Eicosanoid biosynthesis occurs after the release of arachidonic acid from cell membranes by phospholipase A2 (<italic>e</italic>.<italic>g</italic>., cPLA<sub>2</sub>). Arachidonic acid is converted to thromboxane and prostaglandins by cyclooxygenases (COX1/2), whereas 12&#x02010;HETE (12&#x02010;hydroxyeicosatetraenoic acid), 15&#x02010;HETE, 5&#x02010;HETE and leukotrienes are synthesized by lipoxygenases (12/15&#x02010;LOX and 5-LOX). (C-I) 1.5&#x000d7;10<sup>7</sup> wildtype (WT) BMDMs were stimulated with <italic>A</italic>. <italic>phagocytophilum</italic> (MOI25) overnight. Cells were scraped followed by sonication. Enzymatic activities of (C) cPLA<sub>2</sub>, (D) COX1 and (E) COX2 were measured. Levels of (F) arachidonic acid (AA), (G) PGE<sub>2</sub>, (H) PGD<sub>2</sub>, and (I) TBXA<sub>2</sub> in the supernatants of WT BMDMs infected with <italic>A</italic>. <italic>phagocytophilum</italic> (MOI50) were detected. Student&#x02019;s t test. *<italic>P</italic> &#x0003c; 0.05. (-) non-stimulated.</p></caption><graphic xlink:href="ppat.1005803.g001"/></fig></sec><sec id="sec004"><title>cPLA<sub>2</sub> promotes activation of the <italic>A</italic>. <italic>phagocytophilum</italic>-induced NLRC4 inflammasome</title><p>Eicosanoids have been associated with NLRC4 inflammasome activation [<xref rid="ppat.1005803.ref036" ref-type="bibr">36</xref>] and phospholipase A2 releases arachidonic acid from phospholipids for eicosanoid biosynthesis (<xref ref-type="fig" rid="ppat.1005803.g001">Fig 1B</xref>) [<xref rid="ppat.1005803.ref035" ref-type="bibr">35</xref>]. Therefore, we examined whether cPLA<sub>2</sub> was regulating the <italic>A</italic>. <italic>phagocytophilum</italic>-induced NLRC4 inflammasome. Pharmacological inhibition of cPLA<sub>2</sub>, but not other phospholipases [<italic>e</italic>.<italic>g</italic>., soluble phospholipase A<sub>2</sub> (sPLA<sub>2</sub>), phospholipase C (PLC) and phospholipase D (PLD)] reduced the levels of PGE<sub>2</sub>, PGD<sub>2</sub> and TBXA<sub>2</sub> upon <italic>A</italic>. <italic>phagocytophilum</italic> infection of macrophages (<xref ref-type="fig" rid="ppat.1005803.g002">Fig 2A&#x02013;2C</xref>). We also observed lower levels of IL-1&#x003b2;, IL-18 and caspase-1 activation upon bacterial stimulation of immune cells (<xref ref-type="fig" rid="ppat.1005803.g002">Fig 2D, 2E and 2G</xref>). Similar results were obtained with macrophages deficient in cPLA<sub>2</sub> at low and high <italic>A</italic>. <italic>phagocytophilum</italic> multiplicity of infection (MOI) (<xref ref-type="fig" rid="ppat.1005803.g003">Fig 3A&#x02013;3F and 3H</xref>), indicating that pharmacological inhibition of cPLA<sub>2</sub> does not lead to off-target effects and the results obtained occurred independently of bacterial numbers. Importantly, secretion of IL-6 and translation of IL-1&#x003b2; and IL-18 by macrophages, which are not regulated by the inflammasome, remained unaffected during pre-treatment of macrophages with pharmacological inhibitors or in the absence of cPLA<sub>2</sub> (<xref ref-type="fig" rid="ppat.1005803.g002">Fig 2F and 2G</xref> and <xref ref-type="fig" rid="ppat.1005803.g003">Fig 3G and 3H</xref>).</p><fig id="ppat.1005803.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1005803.g002</object-id><label>Fig 2</label><caption><title>Chemical inhibition of cPLA<sub>2</sub> affects the <italic>A</italic>. <italic>phagocytophilum</italic>-induced NLRC4 inflammasome.</title><p>Wildtype (WT) BMDMs (1 x10<sup>6</sup> cells) pre-treated for 30 minutes with pharmacological inhibitors of secreted PLA<sub>2</sub> (sPLA<sub>2</sub>) (LY315920&#x02013;10&#x003bc;M), cPLA<sub>2</sub> (AACOCF3&#x02013;10&#x003bc;M), phospholipase C (PLC) (U73122- 10&#x003bc;M) and phospholipase D (PLD) (FIPI&#x02013; 0.3&#x003bc;M) and infected with <italic>A</italic>. <italic>phagocytophilum</italic> (MOI50) for 18 hours. (A) PGE<sub>2</sub>, (B) PGD<sub>2</sub>, (C) TBXA<sub>2,</sub> (D) IL-1&#x003b2;, (E) IL-18 and (F) IL-6 levels were measured by ELISA in the cell culture supernatants. (G) SDS-PAGE immunoblot (IB) of caspase-1 p20. pro-IL-1&#x003b2; and pro-IL-18 detected in cell lysates. One way ANOVA-Tukey. *<italic>P</italic>&#x0003c; 0.05. NS&#x02013;not significant. (-), non-stimulated.</p></caption><graphic xlink:href="ppat.1005803.g002"/></fig><fig id="ppat.1005803.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1005803.g003</object-id><label>Fig 3</label><caption><title>cPLA<sub>2</sub> regulates the <italic>A</italic>. <italic>phagocytophilum</italic>-induced NLRC4 inflammasome.</title><p>BMDMs (1 x10<sup>6</sup> cells) from wildtype (WT) or cPLA<sub>2</sub>-deficient mice were infected with <italic>A</italic>. <italic>phagocytophilum</italic> (MOI 10/50) for 18 hours. (A) cPLA<sub>2</sub> enzymatic activity was measured. Release of (B) PGE<sub>2</sub>, (C) PGD<sub>2</sub>, (D) TBXA<sub>2,</sub> (E) IL-1&#x003b2;, (F) IL-18 and (G) IL-6 were measured by ELISA in the cell culture supernatants. (H) SDS-PAGE immunoblot (IB) of caspase-1 (p20) in the supernatants. pro-IL-1&#x003b2; and pro-IL-18 were detected in cell lysates. Student&#x02019;s t test. *<italic>P</italic> &#x0003c; 0.05. NS&#x02013;not significant. (-) non-stimulated.</p></caption><graphic xlink:href="ppat.1005803.g003"/></fig><p>Surprisingly, chemical inhibition or genetic ablation of cPLA<sub>2</sub> did not affect caspase-1 autoproteolysis and cytokine secretion when macrophages were infected with <italic>Salmonella</italic> (<xref ref-type="supplementary-material" rid="ppat.1005803.s001">S1 Fig</xref>), a pathogen that stimulates the NLRC4 inflammasome through the T3SS and flagellin [<xref rid="ppat.1005803.ref018" ref-type="bibr">18</xref>&#x02013;<xref rid="ppat.1005803.ref024" ref-type="bibr">24</xref>]. Altogether, these results revealed that although both <italic>A</italic>. <italic>phagocytophilum</italic> and <italic>Salmonella</italic> trigger formation of the NLRC4 inflammasome, the signaling cascades that enable its activation appeared fundamentally different.</p></sec><sec id="sec005"><title>PGE<sub>2</sub> stimulates assembly of the <italic>A</italic>. <italic>phagocytophilum</italic>-induced NLRC4 inflammasome</title><p>To gain better insights into the <italic>A</italic>. <italic>phagocytophilum</italic>-induced NLRC4 inflammasome pathway, we pre-treated macrophages with the pan-COX inhibitor indomethacin [<xref rid="ppat.1005803.ref037" ref-type="bibr">37</xref>]. Pre-treatment of cells with indomethacin followed by <italic>A</italic>. <italic>phagocytophilum</italic> infection decreased the release of PGE<sub>2</sub>, PGD<sub>2</sub>, TBXA<sub>2</sub>, secretion of IL-1&#x003b2; and IL-18, NLRC4 oligomerization and caspase-1 activation, but not IL-6 secretion by macrophages (<xref ref-type="fig" rid="ppat.1005803.g004">Fig 4</xref>). To the contrary, pharmacological inhibition of lipoxygenase enzymes, 12/15-LOX (PD146176) or 5-LOX (AA861), did not affect any of the parameters measured (<xref ref-type="fig" rid="ppat.1005803.g004">Fig 4</xref>). Next, we pre-treated cells with celecoxib, a highly selective COX2 inhibitor [<xref rid="ppat.1005803.ref038" ref-type="bibr">38</xref>], followed by <italic>A</italic>. <italic>phagocytophilum</italic> infection. Pre-treatment of wildtype macrophages with celecoxib or, alternatively, <italic>A</italic>. <italic>phagocytophilum</italic> infection of COX2 (<italic>Ptgs2</italic>)-deficient macrophages blunted the release of prostanoids, IL-1&#x003b2; and IL-18, but not IL-6 secretion (<xref ref-type="fig" rid="ppat.1005803.g005">Fig 5A&#x02013;5F</xref> and <xref ref-type="fig" rid="ppat.1005803.g006">Fig 6A&#x02013;6F</xref>). <italic>A</italic>. <italic>phagocytophilum</italic> infection of COX2 (<italic>Ptgs2</italic>)-deficient macrophages and celecoxib inhibition of COX2 also decreased NLRC4 oligomerization and caspase-1 activation upon <italic>A</italic>. <italic>phagocytophilum</italic> infection (<xref ref-type="fig" rid="ppat.1005803.g005">Fig 5G and 5H</xref> and <xref ref-type="fig" rid="ppat.1005803.g006">Fig 6G and 6H</xref>). As expected, no effect was observed for TLR4-deficient macrophages (<xref ref-type="fig" rid="ppat.1005803.g006">Fig 6</xref>), as <italic>A</italic>. <italic>phagocytophilum</italic> does not carry genes for the biosynthesis of LPS in its genome [<xref rid="ppat.1005803.ref009" ref-type="bibr">9</xref>]. Strikingly, <italic>Salmonella</italic> infection or nigericin stimulation of the NLRP3 inflammasome in COX2 (<italic>Ptgs2</italic>)-deficient macrophages had no effect on the release of IL-1&#x003b2;, IL-18, IL-6, inflammasome oligomerization or caspase-1 activation (<xref ref-type="supplementary-material" rid="ppat.1005803.s002">S2B&#x02013;S2F Fig</xref>). Secretion of PGE<sub>2</sub> served as positive control for this experiment (<xref ref-type="supplementary-material" rid="ppat.1005803.s002">S2A Fig</xref>).</p><fig id="ppat.1005803.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1005803.g004</object-id><label>Fig 4</label><caption><title>The COX pathway mediates the <italic>A</italic>. <italic>phagocytophilum</italic>-induced NLRC4 inflammasome.</title><p>Wildtype (WT) BMDMs (1 x10<sup>6</sup> cells) were pre-treated with indomethacin (100 nM), AA861 (1&#x003bc;g/ml) and PD146176 (1&#x003bc;g/ml) for 2 hours followed by <italic>A</italic>. <italic>phagocytophilum</italic> infection (MOI50) for 18 hours. The levels of (A) PGE<sub>2</sub>, (B) PGD<sub>2</sub>, (C) TBXA<sub>2,</sub> (D) IL-1&#x003b2;, (E) IL-18 and (F) IL-6 were measured by ELISA in the cell culture supernatants. (G) NLRC4 detection by native gel/immunoblotting (IB) and (H) SDS-PAGE caspase-1 western blot indicating autoproteolysis (p20). Pro-IL-1&#x003b2; and IL-18 were used as loading controls. One-way ANOVA-Tukey *<italic>P</italic> &#x0003c; .05; NS, not significant. (-) non-stimulated.</p></caption><graphic xlink:href="ppat.1005803.g004"/></fig><fig id="ppat.1005803.g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1005803.g005</object-id><label>Fig 5</label><caption><title>COX2 regulates the <italic>A</italic>. <italic>phagocytophilum</italic>-induced NLRC4 inflammasome.</title><p>Wildtype (WT) BMDMs (1 x10<sup>6</sup> cells) were pre-treated with celecoxib (0.1&#x003bc;M to 10 &#x003bc;M) for 2 hours followed by <italic>A</italic>. <italic>phagocytophilum</italic> infection (MOI50) for 18 hours. The levels of (A) PGE<sub>2</sub>, (B) PGD<sub>2</sub>, (C) TBXA<sub>2,</sub> (D) IL-1&#x003b2;, (E) IL-18 and (F) IL-6 were measured by ELISA in the cell culture supernatants. (G) SDS-PAGE/Western blot (IB) indicating caspase-1 autoproteolysis (p20). (H) NLRC4 inflammasome oligomer detection in the supernatants by native gel/immunoblotting (IB). One-way ANOVA-Tukey *<italic>P</italic> &#x0003c; .05; NS, not significant. (-) non-stimulated.</p></caption><graphic xlink:href="ppat.1005803.g005"/></fig><fig id="ppat.1005803.g006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1005803.g006</object-id><label>Fig 6</label><caption><title>COX2 modulates NLRC4 inflammasome activity upon <italic>A</italic>. <italic>phagocytophilum</italic> infection.</title><p>BMDMs (1 x10<sup>6</sup> cells) from wildtype (WT), <italic>Tlr4</italic>- and COX2 (<italic>Ptgs2</italic>)-deficient mice were infected with <italic>A</italic>. <italic>phagocytophilum</italic> (MOI 10/50) for 18 hours. The levels of (A) PGE<sub>2</sub>, (B) PGD<sub>2</sub>, (C) TBXA<sub>2,</sub> (D) IL-1&#x003b2;, (E) IL-18 and (F) IL-6 were measured by ELISA in the cell culture supernatants. (G) Caspase-1 (p20) native gel and (H) immunoblotting (IB). &#x003b2;-Actin, pro-IL-1&#x003b2; and pro-IL-18 detected in lysates. One way ANOVA-Tukey. *<italic>P</italic>&#x0003c; 0.05. NS&#x02013;not significant. (-) non-stimulated.</p></caption><graphic xlink:href="ppat.1005803.g006"/></fig></sec><sec id="sec006"><title><italic>A</italic>. <italic>phagocytophilum</italic>-induced NLRC4 inflammasome activation is coupled to the PGE<sub>2</sub>-EP3 receptor</title><p>The enzymatic activity of COX2 leads to the biosynthesis of prostanoids [<xref rid="ppat.1005803.ref038" ref-type="bibr">38</xref>]. To determine which prostanoid affected the <italic>A</italic>. <italic>phagocytophilum</italic>-induced NLRC4 inflammasome, we performed a multi-pronged approach that included pharmacological inhibition, &#x0201c;add-back&#x0201d; assays and gene-targeted deletion of the membrane associated prostaglandin E synthase-1 (mPGES-1), the terminal enzyme that catalyzes the isomerization of PGH<sub>2</sub> to PGE<sub>2</sub> [<xref rid="ppat.1005803.ref029" ref-type="bibr">29</xref>, <xref rid="ppat.1005803.ref030" ref-type="bibr">30</xref>]. First, we observed that addition of PGE<sub>2</sub> in macrophages deficient for <italic>ptgs2</italic> (COX2) restored caspase-1 function and IL-1&#x003b2; and IL-18 secretion upon <italic>A</italic>. <italic>phagocytophilum</italic> infection (<xref ref-type="fig" rid="ppat.1005803.g007">Fig 7A&#x02013;7C</xref>). Conversely, the prostanoids PGD<sub>2</sub> and TBXA<sub>2</sub> did not elicit the activation of the NLRC4 inflammasome in the presence of <italic>A</italic>. <italic>phagocytophilum</italic> (<xref ref-type="fig" rid="ppat.1005803.g007">Fig 7A&#x02013;7C</xref>). Second, specific pharmacological inhibition of the terminal PGE<sub>2</sub> synthase enzyme, mPGES1 [<xref rid="ppat.1005803.ref029" ref-type="bibr">29</xref>, <xref rid="ppat.1005803.ref030" ref-type="bibr">30</xref>], led to reduced caspase-1 activation and IL-1&#x003b2; and IL-18 secretion upon <italic>A</italic>. <italic>phagocytophilum</italic> infection in a dose-dependent manner (<xref ref-type="fig" rid="ppat.1005803.g007">Fig 7D&#x02013;7H</xref>). Third, PGE<sub>2</sub> &#x0201c;add-back&#x0201d; assays restored the phenotype in <italic>mPGES1</italic><sup>-/-</sup> macrophages during <italic>A</italic>. <italic>phagocytophilum</italic> infection (<xref ref-type="fig" rid="ppat.1005803.g007">Fig 7I&#x02013;7M</xref>). Importantly, secretion of IL-6 and translation of IL-1&#x003b2; and IL-18 by macrophages, which are not regulated by the inflammasome, remained unaffected during pharmacological inhibition, &#x0201c;add-back&#x0201d; and gene-targeted deletion assays (<xref ref-type="fig" rid="ppat.1005803.g007">Fig 7C, 7H and 7M</xref> and <xref ref-type="supplementary-material" rid="ppat.1005803.s003">S3 Fig</xref>). Collectively, we provide convincing evidence that PGE<sub>2</sub> is the sole eicosanoid that induces the activation of the NLRC4 inflammasome upon <italic>A</italic>. <italic>phagocytophilum</italic> infection.</p><fig id="ppat.1005803.g007" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1005803.g007</object-id><label>Fig 7</label><caption><title>PGE<sub>2</sub> activates the <italic>A</italic>. <italic>phagocytophilum</italic>-induced NLRC4 inflammasome.</title><p>(A-C) <italic>Ptgs2</italic><sup>-/-</sup> BMDMs (1 x10<sup>6</sup> cells) were infected with <italic>A</italic>. <italic>phagocytophilum</italic> (MOI50) for 4 hours followed by addition of PGE<sub>2</sub> (10 &#x003bc;M), PGD<sub>2</sub> (10 &#x003bc;M) or TBXA<sub>2</sub> (10 &#x003bc;M) for 18 hours. (A) Levels of IL-1&#x003b2; and (B) IL-18 in supernatants were measured by ELISA. (C) Caspase-1 autoproteolysis was measured in supernatants of infected cells. pro-IL-1&#x003b2;, pro-IL-18 and &#x003b2;-actin were detected in cell lysates with SDS-PAGE immunoblot (IB). (D-H) Wildtype (WT) BMDMs (1 x10<sup>6</sup> cells) were pre-treated with the specific inhibitor of mPGES1 (CAY10526&#x02013;1 &#x003bc;M) for 30 minutes followed by <italic>A</italic>. <italic>phagocytophilum</italic> infection (MOI50) for 18 hours. The levels of (D) PGE<sub>2</sub>, (E) PGD<sub>2</sub>, (F) IL-1&#x003b2; and (G) IL-18 in the culture supernatants were measured by ELISA. (H) Caspase-1 p20 autoproteolysis in culture supernatants. pro-IL-1&#x003b2;, pro-IL-18 and &#x003b2;-actin were detected in cell lysates with a SDS-PAGE immunoblot. (I-J) WT and <italic>mPGES1</italic><sup>-/-</sup> BMDMs (1 x10<sup>6</sup> cells) were infected with <italic>A</italic>. <italic>phagocytophilum</italic> (MOI50) for 18 hours. The levels of (I) PGE<sub>2</sub> and (J) PGD<sub>2</sub> were measured in culture supernatants by ELISA. (K-M) <italic>mPGES1</italic><sup>-/-</sup> BMDMs (1 x10<sup>6</sup> cells) were infected with <italic>A</italic>. <italic>phagocytophilum</italic> for 4 hours followed by addition of PGE<sub>2</sub> at indicated concentrations for 18 hours. (K) IL-1&#x003b2; and (L) IL-18 levels in cell culture supernatants were measured by ELISA. (M) Caspase-1 autoproteolysis in cell culture supernatants. pro-IL-1&#x003b2;, pro-IL-18 and &#x003b2;-actin in cell lysates were detected with SDS-PAGE immunoblot (IB). One-way ANOVA-Tukey and Student&#x02019;s t test; <italic>*P</italic> &#x0003c; .05; NS, not significant. (-) non-stimulated.</p></caption><graphic xlink:href="ppat.1005803.g007"/></fig></sec><sec id="sec007"><title>RIPK2 elicits NLRC4 inflammasome activity during <italic>A</italic>. <italic>phagocytophilum</italic> infection</title><p>Next, we performed a kinetics experiment in macrophages to better characterize <italic>A</italic>. <italic>phagocytophilum</italic> infection in the context of NLRC4 inflammasome biology. As previously shown, <italic>A</italic>. <italic>phagocytophilum</italic> was undetectable inside macrophages at 2-hours post-infection [<xref rid="ppat.1005803.ref027" ref-type="bibr">27</xref>]. A small number of bacteria was observed at 6 hours, followed by an increased load at 18 hours and reduction at 48 hours, which led to almost complete elimination after 72 hours of infection in macrophages (<xref ref-type="fig" rid="ppat.1005803.g008">Fig 8A</xref>) [<xref rid="ppat.1005803.ref027" ref-type="bibr">27</xref>]. Consistently, PGE<sub>2</sub> secretion, caspase-1 activation and IL-1&#x003b2; and IL-18 secretion but not IL-6, peaked at 18 hours, the same time point where the greatest number of <italic>A</italic>. <italic>phagocytophilum</italic> was detected inside macrophages (<xref ref-type="fig" rid="ppat.1005803.g008">Fig 8A&#x02013;8D</xref> and <xref ref-type="supplementary-material" rid="ppat.1005803.s004">S4A Fig</xref>).</p><fig id="ppat.1005803.g008" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1005803.g008</object-id><label>Fig 8</label><caption><title>NLRC4 inflammasome activation is dependent on <italic>A</italic>. <italic>phagocytophilum</italic> internalization and RIPK2 function in macrophages.</title><p>(A-D) Wildtype (WT) BMDMs (1 x10<sup>6</sup> cells) were infected with <italic>A</italic>. <italic>phagocytophilum</italic> (MOI 50). Cell culture supernatants and lysates were collected at indicated time points post-infection. (A) Caspase-1 autoproteolysis was detected in cell culture supernatants, whereas the presence of <italic>A</italic>. <italic>phagocytophilum</italic>, pro-IL-1&#x003b2;, pro-IL-18 and &#x003b2;-actin are shown in cell lysates with SDS-PAGE immunoblots (IB). The levels of (B) PGE<sub>2</sub>, (C) IL-1&#x003b2; and (D) IL-6 were measured in cell culture supernatants by ELISA. (E-G) BMDMs from WT and <italic>Ripk2</italic><sup>-/-</sup> mice were infected with <italic>A</italic>. <italic>phagocytophilum</italic> (MOI50) (1 x10<sup>6</sup> cells) for 18 hours. The levels of (E) PGE<sub>2</sub>, (F) IL-1&#x003b2; and (G) IL-6 were measured in cell culture supernatants by ELISA. (H) Caspase-1 autoproteolysis was measured in cell culture supernatants, whereas pro-IL-1&#x003b2;, pro-IL-18, p-I&#x003ba;B, I&#x003ba;B, p-ERK, ERK, COX2 and &#x003b2;-actin were detected in cell lysates by immunoblotting (IB). (I-K) WT BMDMs (1 x10<sup>6</sup> cells) were pre-treated with indicated concentrations of cytochalasin D for 30 minutes followed by <italic>A</italic>. <italic>phagocytophilum</italic> infection (MOI50) for 18 hours. The levels of (I) IL-1&#x003b2; and (J) IL-6 in cell culture supernatants were measured by ELISA. (K) Caspase-1 autoproteolysis was detected in cell culture supernatants. pro-IL-1&#x003b2;, pro-IL-18 and &#x003b2;-actin were detected in cell lysates with SDS-PAGE immunoblot (IB). One-way ANOVA-Tukey and Student&#x02019;s t test. <italic>*P</italic> &#x0003c; .05; NS, not significant. (-) non-stimulated.</p></caption><graphic xlink:href="ppat.1005803.g008"/></fig><p><italic>A</italic>. <italic>phagocytophilum</italic> does not synthesize LPS or peptidoglycans [<xref rid="ppat.1005803.ref008" ref-type="bibr">8</xref>, <xref rid="ppat.1005803.ref009" ref-type="bibr">9</xref>, <xref rid="ppat.1005803.ref011" ref-type="bibr">11</xref>]. Therefore, one interesting immunological question pertains to the host molecule that induces NF-&#x003ba;B activation upon infection. We reasoned that RIPK2 could be this master regulator. This hypothesis rested on four findings. First, RIPK2 activates NF-&#x003ba;B signaling and mitogen activated protein (MAP) kinases upon infection [<xref rid="ppat.1005803.ref013" ref-type="bibr">13</xref>]. Second, <italic>A</italic>. <italic>phagocytophilum</italic> interacts with the host endoplasmic reticulum (ER) [<xref rid="ppat.1005803.ref039" ref-type="bibr">39</xref>], which may exert RIPK2 activity in the absence of peptidoglycans due to cellular stress [<xref rid="ppat.1005803.ref040" ref-type="bibr">40</xref>]. Third, COX2 expression is regulated through a signaling cascade that converges at the MAP kinase and the NF-&#x003ba;B pathways [<xref rid="ppat.1005803.ref041" ref-type="bibr">41</xref>]. Fourth, mice deficient in RIPK2 are susceptible to <italic>A</italic>. <italic>phagocytophilum</italic> infection and secrete reduced levels of IL-18 in the peripheral blood [<xref rid="ppat.1005803.ref014" ref-type="bibr">14</xref>]. Accordingly, <italic>ripk2</italic><sup><italic>-/-</italic></sup> macrophages exhibited a defect in NF-&#x003ba;B and MAP kinase signaling, which led to decreased translation of COX2, pro-IL-1&#x003b2; and IL-6 secretion (<xref ref-type="fig" rid="ppat.1005803.g008">Fig 8G and 8H</xref>). RIPK2 activity also affected PGE<sub>2</sub> release and caspase-1 autoproteolysis upon <italic>A</italic>. <italic>phagocytophilum</italic> infection, as indicated by reduced levels of PGE<sub>2,</sub> IL-1&#x003b2;, IL-18 and caspase-1 activation in cell culture supernatants of <italic>ripk2</italic><sup><italic>-/-</italic></sup> macrophages (<xref ref-type="fig" rid="ppat.1005803.g008">Fig 8E, 8F and 8H</xref> and <xref ref-type="supplementary-material" rid="ppat.1005803.s004">S4B Fig</xref>). Finally, <italic>A</italic>. <italic>phagocytophilum</italic> internalization was important for PGE<sub>2</sub> release and NLRC4 inflammasome activation, as demonstrated in our experiments with cytochalasin D, a potent mycotoxin that inhibits actin polymerization (<xref ref-type="fig" rid="ppat.1005803.g008">Fig 8I&#x02013;8K</xref> and <xref ref-type="supplementary-material" rid="ppat.1005803.s004">S4C and S4D Fig</xref>). Collectively, we identified RIPK2 as a major regulator of the innate immune response against <italic>A</italic>. <italic>phagocytophilum</italic>.</p></sec><sec id="sec008"><title>The PGE<sub>2</sub>-EP3 receptor regulates activation of the NLRC4 inflammasome upon <italic>A</italic>. <italic>phagocytophilum</italic> infection</title><p>We then blunted the PGE<sub>2</sub> signaling cascade with chemical antagonists that bind covalently to the four PGE<sub>2</sub> receptor subtypes (EP1-EP4) [<xref rid="ppat.1005803.ref030" ref-type="bibr">30</xref>] and compared our findings with <italic>Salmonella</italic>. We observed that inhibition of the PGE<sub>2</sub>-EP3 receptor significantly decreased IL-1&#x003b2; and IL-18 release, and caspase-1 activation, but not IL-6 secretion upon <italic>A</italic>. <italic>phagocytophilum</italic> infection (<xref ref-type="fig" rid="ppat.1005803.g009">Fig 9C&#x02013;9E</xref> and <xref ref-type="supplementary-material" rid="ppat.1005803.s005">S5 Fig</xref>). The EP3 receptor for PGE<sub>2</sub> is sensitive to pertussis toxin (PT) [<xref rid="ppat.1005803.ref042" ref-type="bibr">42</xref>]. Macrophages pre-treated with PT and then stimulated with <italic>A</italic>. <italic>phagocytophilum</italic> also resulted in inhibition of the NLRC4 inflammasome (<xref ref-type="supplementary-material" rid="ppat.1005803.s005">S5A&#x02013;S5D Fig</xref>). Importantly, the catalytically inactive pertussis toxin (PT*), with a two amino acid substitution (9K129G) [<xref rid="ppat.1005803.ref043" ref-type="bibr">43</xref>], did not block PGE<sub>2</sub> signaling upon <italic>A</italic>. <italic>phagocytophilum</italic> colonization (<xref ref-type="supplementary-material" rid="ppat.1005803.s005">S5A&#x02013;S5D Fig</xref>). Next, we took advantage of the <italic>ep3</italic><sup>-/-</sup> mice and showed that in the absence of the EP3 receptor molecule, <italic>A</italic>. <italic>phagocytophilum</italic> did not induce caspase-1 activation and IL-1&#x003b2; and IL-18 secretion by macrophages (<xref ref-type="fig" rid="ppat.1005803.g009">Fig 9F&#x02013;9I</xref>). Conversely, lack of the PGE<sub>2</sub>-EP3 receptor did not affect the NLRC4 inflammasome induced by <italic>Salmonella</italic> (<xref ref-type="fig" rid="ppat.1005803.g009">Fig 9J&#x02013;9M</xref> and <xref ref-type="supplementary-material" rid="ppat.1005803.s006">S6 Fig</xref>).</p><fig id="ppat.1005803.g009" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1005803.g009</object-id><label>Fig 9</label><caption><title>The PGE<sub>2</sub>-EP3 axis regulates activation of the NLRC4 inflammasome upon <italic>A</italic>. <italic>phagocytophilum</italic> infection.</title><p>(A-B) Wildtype (WT) BMDMs (1 x10<sup>6</sup> cells) were infected with <italic>A</italic>. <italic>phagocytophilum</italic> (MOI50) for 18 hours or <italic>Salmonella</italic> (MOI25) for 1 hour. RNA and protein levels of the PGE<sub>2</sub>-EP3 receptor was measured by qRT-PCR and western blot (IB). &#x003b2;-actin was also detected in cell lysates. (C-E) WT BMDMs (1 x10<sup>6</sup> cells) was pre-treated with the EP3 antagonist (L-798106) for 30 minutes at indicated concentrations followed by <italic>A</italic>. <italic>phagocytophilum</italic> colonization (MOI50) for 18 hours. The levels of (C) IL-1&#x003b2; and (D) IL-6 were measured in cell culture supernatants by ELISA. (E) Caspase-1 autoproteolysis in cell culture supernatants. pro-IL-1&#x003b2;, pro-IL-18 and &#x003b2;-actin were detected in cell lysates by SDS-PAGE immunoblots (IB). (F-H) WT and <italic>Ep3</italic><sup>-/-</sup> BMDMs (1 x10<sup>6</sup> cells) were infected with <italic>A</italic>. <italic>phagocytophilum</italic> (MOI 10/50) for 18 hours. The levels of (F) IL-1&#x003b2;, (G) IL-18 and (H) IL-6 in culture supernatants were measured by ELISAs. (I) Caspase-1 autoproteolysis in cell culture supernatants. pro-IL-1&#x003b2;, pro-IL-18 and &#x003b2;-actin were detected in cell lysates by SDS-PAGE immunoblots (IB). (J-M) Na&#x000ef;ve or LPS-primed (50 ng/ml) WT and <italic>Ep3</italic><sup>-/-</sup> BMDMs (1 x10<sup>6</sup> cells) were infected with <italic>Salmonella</italic> (MOI25) for 1 hour. The levels of (J) IL-1&#x003b2;, (K) IL-18 and (L) IL-6 in cultured supernatants were measured by ELISA. (M) Caspase-1 autoproteolysis in cell culture supernatants. pro-IL-1&#x003b2;, pro-IL-18 and &#x003b2;-actin were detected in cell lysates by SDS-PAGE immunoblots (IB). Student&#x02019;s t test and ANOVA-Tukey. <italic>*P</italic> &#x0003c; .05; NS, not significant. (-) non-stimulated.</p></caption><graphic xlink:href="ppat.1005803.g009"/></fig><p>PGE<sub>2</sub> exerts its actions by acting on G-protein-coupled receptors (GPCRs). PGE<sub>2</sub> binds to the EP3 receptor, which inhibits the membrane associated adenylyl cyclase via G&#x003b1;i [<xref rid="ppat.1005803.ref044" ref-type="bibr">44</xref>]. This signaling relay decreases cytosolic cyclic AMP (cAMP) production, as adenylyl cyclase catalyzes the conversion of adenosine triphosphate (ATP) to cAMP [<xref rid="ppat.1005803.ref044" ref-type="bibr">44</xref>] (<xref ref-type="supplementary-material" rid="ppat.1005803.s008">S8 Fig</xref>). We validated these observations with sulprostone, an EP3 agonist and positive control in our assays (<xref ref-type="supplementary-material" rid="ppat.1005803.s007">S7A Fig</xref>). Consistently, <italic>A</italic>. <italic>phagocytophilum</italic> colonization of macrophages led to reduced production of cAMP (<xref ref-type="supplementary-material" rid="ppat.1005803.s007">S7A Fig</xref>). Moreover, pharmacological blockade of the PGE<sub>2</sub>-EP3 receptor via the EP3 antagonist or PT hindered the inhibition of cAMP by <italic>A</italic>. <italic>phagocytophilum</italic> (<xref ref-type="supplementary-material" rid="ppat.1005803.s007">S7A Fig</xref>).</p><p>Next, we showed that membrane, but not soluble, adenylyl cyclase modulated the <italic>A</italic>. <italic>phagocytophilum</italic>-induced NLRC4 inflammasome. Forskolin, a selective inhibitor of the membrane-associated adenylyl cyclase [<xref rid="ppat.1005803.ref045" ref-type="bibr">45</xref>], inhibited IL-1&#x003b2;, IL-18 and caspase-1 autoproteolysis during <italic>A</italic>. <italic>phagocytophilum</italic> infection of macrophages (<xref ref-type="supplementary-material" rid="ppat.1005803.s007">S7B&#x02013;S7E Fig</xref>). On the other hand, pre-treatment of macrophages with KH7, a specific pharmacological inhibitor of soluble adenylyl cyclase [<xref rid="ppat.1005803.ref045" ref-type="bibr">45</xref>], did not affect NLRC4 inflammasome function during <italic>A</italic>. <italic>phagocytophilum</italic> infection (<xref ref-type="supplementary-material" rid="ppat.1005803.s007">S7F&#x02013;S7I Fig</xref>). Altogether, these findings: (<italic>i</italic>) indicated that the PGE<sub>2</sub>-EP3 axis is critical for the NLRC4 inflammasome elicited by <italic>A</italic>. <italic>phagocytophilum</italic>; and (<italic>ii</italic>) explained why <italic>Salmonella</italic> is unable to trigger a similar pathway when compared to <italic>A</italic>. <italic>phagocytophilum</italic>. This was likely due to reduced expression of the EP3 receptor during <italic>Salmonella</italic> infection of macrophages (<xref ref-type="fig" rid="ppat.1005803.g009">Fig 9A and 9B</xref>).</p></sec><sec id="sec009"><title>Mice deficient in COX2 are susceptible to <italic>A</italic>. <italic>phagocytophilum</italic></title><p>To prove that the results obtained <italic>in vitro</italic> could also be observed <italic>in vivo</italic>, we then infected mice deficient in COX2 (<italic>Ptgs2</italic>) with <italic>A</italic>. <italic>phagocytophilum</italic>. <italic>Ptgs2</italic>-deficient animals were more susceptible to <italic>A</italic>. <italic>phagocytophilum</italic> infection (<xref ref-type="fig" rid="ppat.1005803.g010">Fig 10A</xref>) and exhibited reduced levels of IL-18 in the peripheral blood when compared to the wildtype mice (<xref ref-type="fig" rid="ppat.1005803.g010">Fig 10B</xref>). As previously seen, no detectable levels of IL-1&#x003b2; were observed in the blood of <italic>A</italic>. <italic>phagocytophilum</italic>-infected mice [<xref rid="ppat.1005803.ref025" ref-type="bibr">25</xref>]. These findings agreed with our prior publications, showing that IL-18 release mediated by RIPK2 and the NLRC4 inflammasome regulates interferon (IFN)-&#x003b3; production by CD4<sup>+</sup> T cells upon <italic>A</italic>. <italic>phagocytophilum</italic> infection [<xref rid="ppat.1005803.ref014" ref-type="bibr">14</xref>, <xref rid="ppat.1005803.ref025" ref-type="bibr">25</xref>]. COX2 (<italic>Ptgs2</italic>)-deficient mice infected with <italic>A</italic>. <italic>phagocytophilum</italic> also revealed lower levels of PGE<sub>2</sub>, PGD<sub>2</sub>, TBXA<sub>2</sub> and splenomegaly (<xref ref-type="fig" rid="ppat.1005803.g010">Fig 10C&#x02013;10G</xref>). COX2 (<italic>Ptgs2</italic>)-deficient animals had increased cellular infiltration in the red pulp and damage to the splenic architecture upon <italic>A</italic>. <italic>phagocytophilum</italic> infection (<xref ref-type="fig" rid="ppat.1005803.g010">Fig 10H</xref>). In sum, these results showed that COX2 is critically important for <italic>A</italic>. <italic>phagocytophilum</italic> infection <italic>in vivo</italic>.</p><fig id="ppat.1005803.g010" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1005803.g010</object-id><label>Fig 10</label><caption><title>COX2 restricts <italic>A</italic>. <italic>phagocytophilum</italic> infection <italic>in vivo</italic>.</title><p><italic>A</italic>. <italic>phagocytophilum</italic> infection of WT (n = 20) and COX2 (<italic>ptgs2)</italic><sup>-/-</sup> (n = 10) mice. Bacterial load in the (A) peripheral blood of infected mice at day 15. (B) IL-18, (C) PGE<sub>2</sub>, (D) PGD<sub>2</sub> and (E) TBXA<sub>2</sub> release in the serum of infected animals. (F-G) Splenomegaly for COX2 (<italic>ptgs2</italic><sup>-/-</sup>) mice infected with <italic>A</italic>. <italic>phagocytophilum</italic>. (H) Splenic architecture depicting the red (RP) and the white (WP) pulp during <italic>A</italic>. <italic>phagocytophilum</italic> infection. One-way ANOVA-Tukey; Student t test; *<italic>P</italic> &#x0003c; 0.05. NS&#x02013;not significant. (-) non-stimulated.</p></caption><graphic xlink:href="ppat.1005803.g010"/></fig></sec></sec><sec sec-type="conclusions" id="sec010"><title>Discussion</title><p>The NLRC4 inflammasome is currently thought to only recognize components of the bacterial T3SS and flagellin [<xref rid="ppat.1005803.ref018" ref-type="bibr">18</xref>&#x02013;<xref rid="ppat.1005803.ref024" ref-type="bibr">24</xref>]. Other inflammasomes, however, such as the NLRP3 scaffold, sense a wide-range of molecular structures leading to caspase-1 activation and cytokine secretion [<xref rid="ppat.1005803.ref016" ref-type="bibr">16</xref>]. We hypothesized that an alternative signaling cascade for the NLRC4 inflammasome must exist because mice deficient in NLRC4 are susceptible to <italic>A</italic>. <italic>phagocytophilum</italic> infection [<xref rid="ppat.1005803.ref025" ref-type="bibr">25</xref>], an obligate intracellular rickettsial bacterium that does not have a T3SS and flagellin [<xref rid="ppat.1005803.ref011" ref-type="bibr">11</xref>]. Furthermore, <italic>Annexin a2</italic>-deficient mice were more susceptible to <italic>A</italic>. <italic>phagocytophilum</italic> infection and showed splenomegaly, thrombocytopenia and monopenia [<xref rid="ppat.1005803.ref028" ref-type="bibr">28</xref>]. Macrophages deficient in Annexin A2, a phospholipid-binding protein, secreted significantly smaller amounts of IL-1&#x003b2; and IL-18 and had a defect in NLRC4 inflammasome oligomerization and caspase-1 activation [<xref rid="ppat.1005803.ref028" ref-type="bibr">28</xref>]. In contrast, <italic>Annexin a2</italic><sup>-/-</sup> macrophages released IL-1&#x003b2;, IL-18, and IL-6 at wild-type levels when infected with <italic>Salmonella</italic>, a canonical NLRC4 agonist [<xref rid="ppat.1005803.ref028" ref-type="bibr">28</xref>].</p><p>We provide unequivocal evidence that two distinct signaling pathways occur for NLRC4 inflammasome activation within the cell: one termed classical (<italic>i</italic>.<italic>e</italic>., stimulated by <italic>Salmonella</italic>) and another referred to as alternative (<italic>i</italic>.<italic>e</italic>. described here, responding to <italic>A</italic>. <italic>phagocytophilum</italic>). Given how inflammasome biology intersects with a growing number of disciplines, we reason that these findings are conceptually valuable because we reveal that eicosanoid receptors in immune cells activate diverging signaling cascades. For instance, both <italic>A</italic>. <italic>phagocytophilum</italic> and <italic>Salmonella</italic> lead to PGE<sub>2</sub> production by macrophages. However, <italic>Salmonella</italic> is unable to activate the eicosanoid-dependent NLRC4 inflammasome pathway because it does not induce PGE<sub>2</sub>-EP3 receptor expression.</p><p>PGE<sub>2</sub> is likely acting in an autocrine/paracrine manner to drive NLRC4 inflammasome activation upon <italic>A</italic>. <italic>phagocytophilum</italic> infection. This is based on the evidence that <italic>A</italic>. <italic>phagocytophilum</italic> infection upregulates the EP3 receptor, which is known to elicit PGE<sub>2</sub> signaling in a cell-intrinsic manner [<xref rid="ppat.1005803.ref030" ref-type="bibr">30</xref>, <xref rid="ppat.1005803.ref035" ref-type="bibr">35</xref>]. Alternatively, PGE<sub>2</sub> may also affect the function of &#x0201c;bystander&#x0201d; cells in a paracrine manner given that our exogenous PGE<sub>2</sub> &#x0201c;add-back&#x0201d; assays restored NLRC4 inflammasome activity in <italic>A</italic>. <italic>phagocytophilum</italic>-infected cells.</p><p>Can rickettsial agents be used to uncover broader principles of immune sensing? The answer to this question may have to deal with the biology of these organisms. Rickettsial agents differ greatly in terms of how they invade and replicate within the mammalian host when compared to other bacteria commonly used to study microbial immunity. Their obligate intracellular life style, coupled to the intense selective pressure to survive both in the arthropod vector and the mammalian host [<xref rid="ppat.1005803.ref001" ref-type="bibr">1</xref>, <xref rid="ppat.1005803.ref002" ref-type="bibr">2</xref>] suggests that these microbes have to employ extreme measures to conceal themselves from the immune system. This reasoning may explain why <italic>A</italic>. <italic>phagocytophilum</italic> triggers such a distinct pathogen-recognition mechanism when compared to other bacteria.</p><p>In summary, we discovered a novel mode of NLRC4 inflammasome activation triggered by the rickettsial bacterium <italic>A</italic>. <italic>phagocytophilum</italic>. We revealed that some microbial pathogens lacking the T3SS and flagellin activate the NLRC4 inflammasome. We also illustrated how this protein scaffold distinguishes bacterial infection within the cell. Altogether, our findings suggest that there are broader yet-to-be discovered principles of microbial sensing in the context of NLRC4 inflammasome biology.</p></sec><sec sec-type="materials|methods" id="sec011"><title>Materials and Methods</title><sec id="sec012"><title>Mice and bacteria</title><p>Breeding and experiments were performed in strict compliance with guidelines set forth by the National Institutes of Health (Office of Laboratory Animal Welfare [OLAW] assurance number A3200-01). Procedures were approved by the Institutional Biosafety (IBC:00002247) and Animal Care and Use (IACUC:0413017 and 0216015) committees at the University of Maryland, Baltimore. <italic>Ripk2</italic><sup>-/-</sup> (007017), C57BL/6 (000664) and <italic>Ptgs2</italic><sup>-/-</sup> (COX2) mice (008101) were purchased from Jackson Laboratories. Femurs from <italic>mPGES1</italic><sup>-/-</sup> [<xref rid="ppat.1005803.ref029" ref-type="bibr">29</xref>] and <italic>Ep3</italic><sup>-/-</sup> [<xref rid="ppat.1005803.ref046" ref-type="bibr">46</xref>] mice were a gift from Leslie Crofford and Richard Breyer at Vanderbilt University School of Medicine. <italic>Tlr4</italic><sup>-/-</sup> and <italic>cPla2</italic><sup><italic>-/-</italic></sup> mice were previously described [<xref rid="ppat.1005803.ref047" ref-type="bibr">47</xref>, <xref rid="ppat.1005803.ref048" ref-type="bibr">48</xref>]. Mice were gender matched and at least 6&#x02013;10 weeks of age. BMDMs were generated, as previously described [<xref rid="ppat.1005803.ref027" ref-type="bibr">27</xref>]. Culturing for the <italic>A</italic>. <italic>phagocytophilum</italic> strain HZ and calculations were described elsewhere [<xref rid="ppat.1005803.ref027" ref-type="bibr">27</xref>]. <italic>Salmonella</italic> strain SL1344 was a gift from Dr. Stefanie Vogel at the University of Maryland, Baltimore School of Medicine. <italic>Salmonella</italic> was grown in HS media at 37&#x000b0;C and enumerated, as previously described [<xref rid="ppat.1005803.ref049" ref-type="bibr">49</xref>]. Cell cultures were tested and determined to be <italic>Mycoplasma</italic>-negative through a commercially available PCR kit (Southern Biotech -13100-01).</p></sec><sec id="sec013"><title>Chemical reagents</title><p>LPS (50ng/ml) was purchased from InvivoGen. Nigericin (10&#x003bc;M), indomethacin (100 nM) and celecoxib (0.1&#x003bc;M to 10 &#x003bc;M) were purchased from Sigma-Aldrich. AA861 (1&#x003bc;g/ml) and PD146176 (1&#x003bc;g/ml) were purchased from BioMol International. CAY10526 (10010088), KH7 (13243), Forskolin (11018), Cytochalasin D (11330), PGE<sub>2</sub> (14010), PGD<sub>2</sub> (12010) and U46619 (thromboxane A2 analogue, 16450) were purchased from Cayman Chemicals. The PGE<sub>2</sub> receptor antagonists EP1&#x02013;1&#x003bc;M (SC51089), EP2&#x02013;5&#x003bc;M (AH6809) and EP4&#x02013;5&#x003bc;M (ONO-AE3-208) were purchased from Cayman Chemical, whereas the antagonist for the PGE<sub>2</sub> EP3&#x02013;10&#x003bc;M (L-798106) and the PGE<sub>2</sub> EP3 receptor agonist (sulprostone&#x02014;3&#x003bc;M) was purchased from Sigma. The inhibitors for the phospholipases cPLA2 (AACOCF3), sPLA2 (LY315920), PLC (U73122) and PLD (FIPI) were purchased from Tocris Bioscience. Pertussis toxin (PT) and the catalytically inactive pertussis toxin (PT*) with a two amino acid substitution (9K129G) were described previously [<xref rid="ppat.1005803.ref043" ref-type="bibr">43</xref>, <xref rid="ppat.1005803.ref050" ref-type="bibr">50</xref>].</p></sec><sec id="sec014"><title>Bacterial infection of macrophages</title><p>1&#x000d7;10<sup>6</sup> BMDMs were seeded into 24-well plate in 300 &#x003bc;l of media containing 5% fetal bovine serum (FBS) overnight prior to the challenge by either <italic>A</italic>. <italic>phagocytophilum</italic> (MOI 10 and 50) or <italic>Salmonella</italic> (MOI 25) for 1 hour. 50ng/ml of LPS was used for cell priming at 37&#x000b0;C and 5% CO<sub>2</sub> for 30 minutes during <italic>Salmonella</italic> infection. LPS-primed cells were washed twice extensively followed by the addition of bacteria. In inhibition assays, 1&#x000d7;10<sup>6</sup> WT and genotype-deficient BMDMs were pre-treated with pharmacological inhibitors at indicated time and concentrations followed by the stimulation with <italic>A</italic>. <italic>phagocytophilum</italic> (MOI 10 and 50) overnight or <italic>Salmonella</italic> (MOI 25) for 1 hour. For the <italic>Ptgs2</italic><sup>-/-</sup> and <italic>mPGES1</italic><sup>-/-</sup> &#x0201c;add-back&#x0201d; experiments, 1&#x000d7;10<sup>6</sup> WT and deficient cells were infected with <italic>A</italic>. <italic>phagocytophilum</italic> (MOI 50) for 4 hours followed by the addition of the respective eicosanoid at indicated concentrations for 18 hours. After infection, cultured supernatants and cell lysates collected from each well were used for ELISA and immunoblot assays.</p></sec><sec id="sec015"><title>Native polyacrylamide gel electrophoresis</title><p>Equal amounts of supernatants were mixed with the native sample buffer (62.5 mM Tris-HCl, 40% glycerol, 0.01% bromophenol blue, pH 6.8), loaded into 4&#x02013;15% Mini-PROTEAN TGX Precast Gels and run at 200 volts for 2 hours in 1&#x000d7;Tris/Glycine native running buffer (25 mM Tris, 192 mM glycine, pH8.3). NativeMark Unstained Protein Standard (Invitrogen) was visualized with Gel Code Blue Safe Protein Stain solution (Thermo Scientific).</p></sec><sec id="sec016"><title>Immunoblotting</title><p>Cell lysates were prepared in radioimmunoprecipitation (RIPA) lysis buffer (Boston Bioproducts) with Halt Protease Inhibitor Cocktail (Thermo Scientific) and PhosSTOP (Roche Applied Science). 4&#x02013;15% Mini-PROTEAN TGX precast gels were run at 200 volts for 30 minutes in the 1&#x000d7;Tris-Glycine-SDS running buffer (Boston Bioproducts). Transfer was performed using the Bio-Rad Trans-Blot Turbo with either polyvinylidene fluoride (PVDF) or nitrocellulose membranes (Bio-Rad). Membranes were blocked in 5% skim milk or BSA (Bio-Rad). Western blot antibodies for caspase-1 (1:1000, Millipore 06&#x02013;503 or 06-503-I, 1:1,000, Proteintech 22915-1-AP; 1:2000 Genentech 4175, cell line 4B4.2.1, or 1:1000, AdiPoGen International AG-20B-0042), NLRC4 (1:1000, Millipore, 06&#x02013;1125), IL-1&#x003b2; (1:1000 R&#x00026;D Systems and Cell Signaling, AF401-NA and 12426S), IL-18 (1:1000, MBL JM-5180-100), &#x003b2;-actin (1:1000, Sigma A2103), COX2 (1:1000, Cell Signaling 12282), phospho-I&#x003ba;B-&#x003b1; (1:1000, Cell Signaling 9246s), p-ERK (1:400, Cell Signaling 4370), ERK (1:1000, Cell Signaling 9102), I&#x003ba;B-&#x003b1; (1:1000, Cell Signaling 4812), PTGER3 (1:1,000, Abcam ab117998), anti-mouse horseradish peroxidase (HRP), anti-goat HRP, anti-rabbit HRP (1:5000, Abcam ab97046, ab97110 and ab97051, respectively), anti-rat HRP (1:5000 Abcam and Santa Cruz Biotechnology, ab97057 and sc-2006) were used. A rabbit polyclonal antibody raised against <italic>A</italic>. <italic>phagocytophilum</italic> [<xref rid="ppat.1005803.ref051" ref-type="bibr">51</xref>] was kindly provided by Erol Fikrig at Yale University School of Medicine (1:2,000). Enhanced chemiluminescence (ECL) western blotting substrate and Super Signal West Pico Chemiluminescent substrate were used (Thermo Scientific). Restore Western Blot Stripping Buffer was used for the stripping of antibodies on the blots (Thermo Scientific).</p></sec><sec id="sec017"><title>ELISA</title><p>IL-1&#x003b2; and IL-6 were measured with the BD OptEIA Set (BD Biosciences). IL-18 capture (1:1,000, D047-3) and detection antibodies (1:2,000, D048-6) were purchased from MBL. PGE<sub>2</sub> was measured with the ELISA kit (Enzo Life Sciences). PGD<sub>2</sub> was measured with the ELISA kit (Cayman Chemicals). Thromboxane A<sub>2</sub> was measured with the Mouse Thromboxane A<sub>2</sub> ELISA Kit (Abbexa).</p></sec><sec id="sec018"><title>Quantitative RT-PCR</title><p>Quantitate RT-PCR was performed using the Power SYBR Green PCR Master Mix (Invitrogen) in an ABI 7500 real-time PCR instrument. Primer sequences for <italic>A</italic>. <italic>phagocytophilum</italic> were as follows: 16S-F (5&#x02019;-CAGCCACACTGGAACTGAGA-3&#x02019;) and 16S-R (5&#x02019;-CCCTAAGGCCTTCCTCACTC-3&#x02019;). Gene expression was normalized by using the primers &#x003b2;-actin-F (5&#x02019;-ACGCAGAGGGAAATCGTGCGTGAC-3&#x02019;) and &#x003b2;-actin-R (5&#x02019;-ACGCGGGAGGAAGAGGATGCGGCAGTG-3&#x02019;). The absolute quantification method was used. For the PGE<sub>2</sub>-EP3 receptor quantification, PureLink RNA Mini Kit (Invitrogen) and the Verso cDNA synthesis Kit (Thermo Scientific) were used. Gene expression was normalized by using the primers GAPDH-F (5&#x02019;-TGATGACATCAAGAAGGTGGTGAAG-3&#x02019;) and GAPDH-R (5&#x02019;-TCCTTGGAGGCCATGTGGGCCAT-3&#x02019;). Primer sequences for the EP3 receptor were as follows: EP3-F (5&#x02019;-GGTTCCTGTGAAGGACTGAAGAC-3&#x02019;) and EP3-R (5&#x02019;-AAGGTTCTGAGGCTGGAGATA-3&#x02019;). The relative quantification method (fold changes) was used.</p></sec><sec id="sec019"><title>Enzymatic assays</title><p>15&#x000d7;10<sup>6</sup> wildtype cells were stimulated with <italic>A</italic>. <italic>phagocytophilum</italic> (MOI 25) overnight. Cells were scraped followed by sonication. COX1/2 enzymatic assays were performed with COX activity assay kit (Cayman Chemicals), whereas cPLA<sub>2</sub> activity was measured following instructions by the manufacturer (Abnova). Arachidonic acid levels were measured according to the instructions of the ELISA kit (MyBiosource). cAMP was measured by using the cyclic AMP XP Assay Kit (Cell Signaling Technology).</p></sec><sec id="sec020"><title>Illumina sequencing and bioinformatics</title><p>BMDMs were grown into 6-well culture plates at 7&#x000d7;10<sup>6</sup> per well. Cells were stimulated with <italic>A</italic>. <italic>phagocytophilum</italic>. Uninfected BMDMs were used as controls and the experiment was performed in triplicate. Total RNA was isolated with the PureLink RNA Mini Kit (Invitrogen). Illumina Sequencing was performed at the University of Maryland, Baltimore. Briefly, Illumina RNAseq libraries were prepared with the TruSeq RNA Sample Prep kit (Illumina, San Diego, CA). The indexed libraries were pooled and sequenced using the HiSeq platform (Illumina) for the mouse samples in order to generate 101 base pair reads. The reads were further trimmed due to low quality at the trailing 3' end. These trimmed paired end reads were populated into 2 separate FASTQ format files and the quality of the reads was tested using the FastQC toolkit to ensure quality of the sequencing reads.</p><p>The RNA sequencing reads were used as input for the TopHat read alignment tool to be aligned to the mouse genomic reference sequence (Ensembl GRCm38 version) for each of the samples. The reference genomic sequences for the GRCm38 genome build were downloaded from the Ensembl resources. The output from TopHat was obtained as BAM format files. In the alignment phase, we allowed up to two mismatches per 30 base pair segment and removed reads that aligned to more than 20 genomic locations. The BAM alignment files obtained from the TopHat alignment tool was analyzed to generate the alignment statistics for each sample, namely, the total number of reads, the number of mapped reads and the percent of mapped reads.</p><p>For the differential gene expression analysis, the alignment BAM files from TopHat were further utilized to compute gene expression levels and test each gene for differential expression. The mouse gene set reference annotation (version GRCm38) in GTF format was downloaded from the Ensembl resources. The number of reads that mapped to each gene described in the Ensembl annotation was calculated using the python package HTSeq-an alignment read count tool. The read count represented the expression of the gene. Differential gene expression analysis was conducted using the DESeq R package (available from Bioconductor). The DESeq analysis resulted in the determination of differentially expressed genes. DESeq utilized the read counts provided by the HTSeq read count tool. The read counts for each sample were normalized for sequencing depth and distortion caused by highly differentially expressed genes. The negative binomial model was used to test the significance of differential expression between two genotypes. The differentially expressed genes were deemed significant if the FDR (False Discovery Rate) was less than 0.01, the gene expression was above the 45th percentile and gene showed greater than 2-fold change difference (over expressed or under expressed) between conditions. Principal component analysis and other clustering methods were used to visualize the clustering of the replicates across samples. Heat maps were generated to illustrate the genes showing significant differences between multiple comparisons of the control and other infection and/or treatment conditions.</p></sec><sec id="sec021"><title><italic>In vivo</italic> infection</title><p>C57BL/6 (n = 20) and COX2 (<italic>Ptgs2)</italic><sup><italic>-/-</italic></sup> (n = 10) mice were infected by intraperitoneal injection with <italic>A</italic>. <italic>phagocytophilum</italic> strain HZ (1&#x000d7;10<sup>7</sup> cells). Blood samples were collected at days 0, 5 and 10 for the IL-18 ELISA. Spleens were removed, normalized to the body weight, and compared to those of non-infected mice. Spleens were fixed at day 15 post-infection with 10% neutral buffered formalin and embedded in paraffin wax. Sections (5 &#x003bc;m) were obtained and stained with hematoxylin and eosin. Measurement of <italic>A</italic>. <italic>phagocytophilum</italic> load was done at day 15 post-infection in the peripheral blood of infected animals using quantitative RT-PCR, as described above.</p></sec><sec id="sec022"><title>Statistical analysis</title><p>All experiments in this study were performed with at least 2&#x02013;5 replicates. All data were expressed as means &#x000b1; standard errors of the means (SEM). The differences between groups were examined by either unpaired Student's <italic>t</italic> test or one-way analysis of variance (ANOVA). All statistical calculations and graphs were made by using GraphPad Prism version 6.0. <italic>P</italic> &#x0003c; 0.05 was considered statistically significant.</p></sec></sec><sec sec-type="supplementary-material" id="sec023"><title>Supporting Information</title><supplementary-material content-type="local-data" id="ppat.1005803.s001"><label>S1 Fig</label><caption><title>The <italic>Salmonella</italic>-induced NLRC4 inflammasome is not affected by inhibition of phospholipases.</title><p>Wildtype (WT) BMDMs (1 x10<sup>6</sup> cells) were pre-treated for 30 minutes with inhibitors of secreted PLA<sub>2</sub> (sPLA<sub>2</sub>) (LY315920&#x02013;10&#x003bc;M), cPLA<sub>2</sub> (AACOCF3&#x02013;10&#x003bc;M), phospholipase C (PLC) (U73122&#x02013;10&#x003bc;M) and phospholipase D (PLD) (FIPI&#x02013; 0.3&#x003bc;M). Cells were then primed with LPS (50ng/ml) and infected with <italic>Salmonella</italic> (MOI25) for 1 hour. (A) IL-1&#x003b2;, (B) IL-18 and (C) IL-6 were measured in cell culture supernatants by ELISA. (D) SDS-PAGE immunoblot (IB) of caspase-1 p20. (E-G) BMDMs from wildtype (WT) or cPLA<sub>2</sub>-deficient mice (1 x10<sup>6</sup> cells) were infected with <italic>Salmonella</italic> (MOI25) for 1 hour. Levels of (E) IL-1&#x003b2; and (F) IL-6 were measured in cell culture supernatants by ELISA. (G) SDS-PAGE followed by immunoblot (IB) of caspase-1 p20 in the supernatants. pro-IL-1&#x003b2; and pro-IL-18 detected in lysates. ANOVA-Tukey. *<italic>P</italic> &#x0003c; 0.05. NS&#x02013;not significant. (-), non-stimulated.</p><p>(TIF)</p></caption><media xlink:href="ppat.1005803.s001.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1005803.s002"><label>S2 Fig</label><caption><title>COX2 does not influence canonical inflammasome activation.</title><p>BMDMs from wildtype (WT) and COX2 (<italic>Ptgs2</italic>)-deficient mice (1 x10<sup>6</sup> cells) primed with LPS (50ng/ml) for 1 hour and infected with <italic>Salmonella</italic> (MOI25&#x02013;1 hour) or stimulated with nigericin (10&#x003bc;M&#x02013; 18 hours). (A) PGE<sub>2,</sub> (B) IL-1&#x003b2;<bold>,</bold> (C) IL-18 and (D) IL-6 release in cell culture supernatants was measured by ELISA. (E) Caspase-1 native gel immunoblotting (IB). (F) SDS-PAGE/Western blot indicating caspase-1 autoproteolysis (p20). Student&#x02019;s t test. *<italic>P</italic>&#x0003c; 0.05. &#x003b2;-actin and pro-IL-18 used as loading controls.</p><p>(TIF)</p></caption><media xlink:href="ppat.1005803.s002.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1005803.s003"><label>S3 Fig</label><caption><title>PGE<sub>2</sub> does not affect IL-6 secretion during <italic>A</italic>. <italic>phagocytophilum</italic> infection.</title><p>(A) <italic>Ptgs2</italic><sup>-/-</sup> BMDMs (1 x10<sup>6</sup> cells) were infected with <italic>A</italic>. <italic>phagocytophilum</italic> for 4 hours followed by addition of PGE<sub>2</sub> (10 &#x003bc;M), PGD<sub>2</sub> (10 &#x003bc;M) or TBXA<sub>2</sub> (10 &#x003bc;M) for 18 hours. IL-6 was measured in the cell culture supernatants by ELISA. (B) Wildtype (WT) BMDMs (1 x10<sup>6</sup> cells) were pre-treated with the mPGES1 inhibitor CAY10526 at indicated concentrations for 30 minutes followed by <italic>A</italic>. <italic>phagocytophilum</italic> infection (MOI50) for 18 hours. IL-6 was measured in the cell culture supernatants by ELISA. (C) <italic>mPGES1</italic><sup>-/-</sup> BMDMs (1 x10<sup>6</sup> cells) were infected with <italic>A</italic>. <italic>phagocytophilum</italic> for 4 hours followed by addition of PGE<sub>2</sub> (10 &#x003bc;M). IL-6 was measured in the cell culture supernatants by ELISA. One-way ANOVA-Tukey. NS, not significant. (-) non-stimulated.</p><p>(TIF)</p></caption><media xlink:href="ppat.1005803.s003.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1005803.s004"><label>S4 Fig</label><caption><title>PGE<sub>2</sub> and IL-18 secretion is dependent on <italic>A</italic>. <italic>phagocytophilum</italic> internalization and RIPK2 function in macrophages.</title><p>(A) Wildtype (WT) BMDMs (1 x10<sup>6</sup> cells) were infected with <italic>A</italic>. <italic>phagocytophilum</italic> (MOI50). Cell culture supernatants were collected at indicated time points post-infection. The levels of (A) IL-18 was measured in cell culture supernatants by ELISA. (B) BMDMs from wildtype (WT) and <italic>Ripk2</italic><sup>-/-</sup> mice were infected with <italic>A</italic>. <italic>phagocytophilum</italic> (MOI50) (1 x10<sup>6</sup> cells) for 18 hours. The levels of IL-18 were measured in cell culture supernatants by ELISA. (C-D) WT BMDMs (1 x10<sup>6</sup> cells) were pre-treated with indicated concentrations of cytochalasin D for 30 minutes followed by <italic>A</italic>. <italic>phagocytophilum</italic> infection (MOI50) for 18 hours. The levels of (C) PGE<sub>2</sub> and (D) IL-18 in cell culture supernatants was measured by ELISA. One-way ANOVA-Tukey; Student&#x02019;s t test. <italic>*P</italic> &#x0003c; .05. NS, not significant. (-) non-stimulated.</p><p>(TIF)</p></caption><media xlink:href="ppat.1005803.s004.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1005803.s005"><label>S5 Fig</label><caption><title>The EP3 receptor modulates NLRC4 inflammasome activity upon <italic>A</italic>. <italic>phagocytophilum</italic> infection.</title><p>Wildtype (WT) BMDMs (1 x10<sup>6</sup> cells) were pre-treated for 30 minutes with antagonists of PGE<sub>2</sub> receptors: (1)&#x02013;(na&#x000ef;ve); (2) (EP1&#x02013;1&#x003bc;M) (SC51089); (3) (EP2&#x02013;5&#x003bc;M) (AH6809); (4) (EP3&#x02013;10&#x003bc;M) (L-798106); (5) (EP4&#x02013;5&#x003bc;M) (ONO-AE3-208); (6) active (PT&#x02013; 0.1&#x003bc;g/ml) and (7) catalytically inactive (PT*&#x02013; 0.1 &#x003bc;g/ml) pertussis toxin and stimulated with (A-D) <italic>A</italic>. <italic>phagocytophilum</italic> (MOI50) for 18 hours. The levels of (A) IL-1&#x003b2;, (B) IL-18 and (C) IL-6 release in cell culture supernatants were measured by ELISA. (D) Caspase-1 autoproteolysis immunoblotting (IB). pro-IL-1&#x003b2; and pro-IL-18 were detected in cell lysates. (E-I) WT BMDMs (1 x10<sup>6</sup> cells) were pre-treated for 30 minutes with the EP3 antagonist or pertussis toxin at indicated concentrations for 30 minutes followed by <italic>A</italic>. <italic>phagocytophilum</italic> infection (MOI50) for 18 hours. (E, G) IL-18; (F) IL-1&#x003b2; and (H) IL-6 release in cell culture supernatants were measured by ELISA. (I) Caspase-1 autoproteolysis immunoblotting (IB). pro-IL-1&#x003b2; and pro-IL-18 were detected in cell lysates. ANOVA-Tukey. <italic>*P</italic> &#x0003c; 0.05. NS&#x02013;not significant. (-), non-stimulated.</p><p>(TIF)</p></caption><media xlink:href="ppat.1005803.s005.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1005803.s006"><label>S6 Fig</label><caption><title>The EP3 receptor does not regulate the activity of the canonical NAIP/NLRC4 inflammasome induced by <italic>Salmonella</italic> infection.</title><p>WT BMDMs (1 x10<sup>6</sup> cells) primed with LPS (50ng/ml) were pre-treated for 30 minutes with antagonists of PGE<sub>2</sub> receptors: (1)&#x02013;(na&#x000ef;ve); (2) (EP1&#x02013;1&#x003bc;M) (SC51089); (3) (EP2&#x02013;5&#x003bc;M) (AH6809); (4) (EP3&#x02013;10&#x003bc;M) (L-798106); (5) (EP4&#x02013;5&#x003bc;M) (ONO-AE3-208); (6) active (PT&#x02013; 0.1&#x003bc;g/ml) and (7) catalytically inactive (PT*&#x02013; 0.1 &#x003bc;g/ml) pertussis toxin and stimulated with (A-C) <italic>Salmonella</italic> (MOI25) for 1 hour. The levels of (A) IL-1&#x003b2; and (B) IL-18 release in cell culture supernatants were measured by ELISA. (C) Caspase-1 autoproteolysis immunoblotting (IB). pro-IL-1&#x003b2; and pro-IL-18 were detected in cell lysates. One way ANOVA-Tukey; NS&#x02013;not significant. (-) non-stimulated.</p><p>(TIF)</p></caption><media xlink:href="ppat.1005803.s006.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1005803.s007"><label>S7 Fig</label><caption><title>Membrane-associated adenylyl cyclase modulates the <italic>A</italic>. <italic>phagocytophilum</italic>-induced NLRC4 inflammasome.</title><p>(A) Wildtype (WT) BMDMs (1 x10<sup>6</sup> cells) were pre-treated with the EP3 agonist sulprostone (3&#x003bc;M), the EP3 antagonist L-798106 (10&#x003bc;M), or active pertussis toxin (PT&#x02013; 0.1&#x003bc;g/ml) for 30 minutes followed by <italic>A</italic>. <italic>phagocytophilum</italic> (MOI50) infection for 18 hours. cAMP levels were measured. (B-I) WT BMDMs (1 x10<sup>6</sup> cells) were pre-treated with the selective (B-E) membrane (Forskolin) or (F-I) soluble (KH7) adenylyl cyclase inhibitors at indicated concentrations for 30 min followed by <italic>A</italic>. <italic>phagocytophilum</italic> colonization (MOI50) for 18 hours. The levels of (B, F) IL-1&#x003b2;, (C, G) IL-18 and (D, H) IL-6 in the cell culture supernatants were measured by ELISA. (E, I) Caspase-1 autoproteolysis was detected with SDS-PAGE immunoblot (IB). Pro-IL-1&#x003b2; and pro-IL-18 were detected in cell lysates. One-way ANOVA-Tukey. *<italic>P</italic> &#x0003c; 0.05. NS&#x02013;not significant. (-) non-stimulated.</p><p>(TIF)</p></caption><media xlink:href="ppat.1005803.s007.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="ppat.1005803.s008"><label>S8 Fig</label><caption><title>Schematic representation of the <italic>A</italic>. <italic>phagocytophilum</italic>-induced NLRC4 inflammasome.</title><p><italic>A</italic>. <italic>phagocytophilum</italic> infection and formation of the occupied vacuole (ApV) leads to disruption and molecular rearrangements within the cell [<xref rid="ppat.1005803.ref028" ref-type="bibr">28</xref>]. (1) Cytosolic phospholipase A2 (cPLA<sub>2</sub>) releases (2) arachidonic acid from phosphatidylinositol 4,5-bisphosphate [PI(<sub>4,5</sub>)P<sub>2</sub>], the major polyphosphoinositide phospholipid present in the inner leaflet of the plasma membrane [<xref rid="ppat.1005803.ref052" ref-type="bibr">52</xref>]. (3) Cyclooxygenase 2 (COX2) and microsomal PGE synthase-1 (mPGES1) [<xref rid="ppat.1005803.ref029" ref-type="bibr">29</xref>] convert hydrolyzed arachidonic acid to prostanglandin E<sub>2</sub> (PGE<sub>2</sub>). PGE<sub>2</sub> exerts its actions by acting on G-protein-coupled receptors (GPCRs). PGE<sub>2</sub> binds to the EP3 receptor, which inhibits the membrane associated adenylyl cyclase (AC) via G&#x003b1;i (4). This signaling relay decreases cytosolic cyclic AMP (cAMP) production. Lower levels of cAMP induce the activation of the NLRC4 inflammasome (5). Receptor-interacting serine/threonine-protein kinase 2 (RIPK2) stimulates the production of pro-IL-1&#x003b2; via nuclear factor (NF)-&#x003ba;B signaling (6). RIPK2 also triggers formation of the NLRC4 inflammasome oligomer through COX2 up-regulation (7) via mitogen-activated protein kinase (MAPK) signaling [<xref rid="ppat.1005803.ref041" ref-type="bibr">41</xref>]. Caspase-1 cleaves pro-IL-1&#x003b2; and pro-IL-18 leading to the release of mature cytokines (8).</p><p>(TIF)</p></caption><media xlink:href="ppat.1005803.s008.tif"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>The authors acknowledge Vishva Dixit (Genentech) for providing the anti-caspase-1 antibody and Erol Fikrig (Yale University School of Medicine) for the anti-<italic>A</italic>. <italic>phagocytophilum</italic> antibody; Stefanie Vogel (University of Maryland, Baltimore School of Medicine) for providing strains of <italic>Salmonella</italic>; Leslie Crofford (Vanderbilt University School of Medicine) and Richard Breyer (Vanderbilt University School of Medicine) for providing mice deficient in the enzyme mPGES1 and the EP3 receptor, respectively; Erin McClure (University of Maryland, Baltimore School of Medicine) for the graphic design; the Core facilities at the University of Maryland, Baltimore for services related to Illumina sequencing, informatics and pathology; Sarah Davis (Vanderbilt University School of Medicine), Elizabeth M. Johnson (Vanderbilt University School of Medicine), Hal Neely (University of Maryland, Baltimore School of Medicine), Martin Flajnik (University of Maryland, Baltimore School of Medicine), Eileen O&#x02019;Leary (Massachusetts General Hospital and Harvard Medical School) and Vickie Knepper-Adrian (University of Iowa School of Medicine) for technical assistance.</p></ack><ref-list><title>References</title><ref id="ppat.1005803.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Rikihisa</surname><given-names>Y</given-names></name>. <article-title><italic>Anaplasma phagocytophilum</italic> and <italic>Ehrlichia chaffeensis</italic>: subversive manipulators of host cells</article-title>. <source>Nat Rev Microbiol</source>. <year>2010</year>;<volume>8</volume>(<issue>5</issue>):<fpage>328</fpage>&#x02013;<lpage>39</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrmicro2318">10.1038/nrmicro2318</ext-link></comment>
<?supplied-pmid 20372158?><pub-id pub-id-type="pmid">20372158</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Walker</surname><given-names>DH</given-names></name>, <name><surname>Ismail</surname><given-names>N</given-names></name>. <article-title>Emerging and re-emerging rickettsioses: endothelial cell infection and early disease events</article-title>. <source>Nat Rev Microbiol</source>. <year>2008</year>;<volume>6</volume>(<issue>5</issue>):<fpage>375</fpage>&#x02013;<lpage>86</lpage>. Epub 2008/04/17. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrmicro1866">10.1038/nrmicro1866</ext-link></comment>
<?supplied-pmid 18414502?><pub-id pub-id-type="pmid">18414502</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Jordan</surname><given-names>JM</given-names></name>, <name><surname>Woods</surname><given-names>ME</given-names></name>, <name><surname>Soong</surname><given-names>L</given-names></name>, <name><surname>Walker</surname><given-names>DH</given-names></name>. <article-title><italic>Rickettsiae</italic> stimulate dendritic cells through toll-like receptor 4, leading to enhanced NK cell activation <italic>in vivo</italic></article-title>. <source>J Infect Dis</source>. <year>2009</year>;<volume>199</volume>(<issue>2</issue>):<fpage>236</fpage>&#x02013;<lpage>42</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1086/595833">10.1086/595833</ext-link></comment>
<?supplied-pmid 19072551?><pub-id pub-id-type="pmid">19072551</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Jordan</surname><given-names>JM</given-names></name>, <name><surname>Woods</surname><given-names>ME</given-names></name>, <name><surname>Olano</surname><given-names>J</given-names></name>, <name><surname>Walker</surname><given-names>DH</given-names></name>. <article-title>The absence of Toll-like receptor 4 signaling in C3H/HeJ mice predisposes them to overwhelming rickettsial infection and decreased protective Th1 responses</article-title>. <source>Infect Immun</source>. <year>2008</year>;<volume>76</volume>(<issue>8</issue>):<fpage>3717</fpage>&#x02013;<lpage>24</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/IAI.00311-08">10.1128/IAI.00311-08</ext-link></comment>
<?supplied-pmid 18490467?><pub-id pub-id-type="pmid">18490467</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Bechelli</surname><given-names>J</given-names></name>, <name><surname>Smalley</surname><given-names>C</given-names></name>, <name><surname>Zhao</surname><given-names>X</given-names></name>, <name><surname>Judy</surname><given-names>B</given-names></name>, <name><surname>Valdes</surname><given-names>P</given-names></name>, <name><surname>Walker</surname><given-names>DH</given-names></name>, <etal>et al</etal>
<article-title>MyD88 mediates instructive signaling in dendritic cells and protective inflammatory response during rickettsial infection</article-title>. <source>Infect Immun</source>. <year>2016</year>;<volume>84</volume>(<issue>4</issue>):<fpage>883</fpage>&#x02013;<lpage>93</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/IAI.01361-15">10.1128/IAI.01361-15</ext-link></comment>
<?supplied-pmid 26755162?><pub-id pub-id-type="pmid">26755162</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Chattoraj</surname><given-names>P</given-names></name>, <name><surname>Yang</surname><given-names>Q</given-names></name>, <name><surname>Khandai</surname><given-names>A</given-names></name>, <name><surname>Al-Hendy</surname><given-names>O</given-names></name>, <name><surname>Ismail</surname><given-names>N</given-names></name>. <article-title>TLR2 and Nod2 mediate resistance or susceptibility to fatal intracellular <italic>Ehrlichia</italic> infection in murine models of ehrlichiosis</article-title>. <source>PLoS One</source>. <year>2013</year>;<volume>8</volume>(<issue>3</issue>):<fpage>e58514</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0058514">10.1371/journal.pone.0058514</ext-link></comment>
<?supplied-pmid 23526993?><pub-id pub-id-type="pmid">23526993</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Koh</surname><given-names>YS</given-names></name>, <name><surname>Koo</surname><given-names>JE</given-names></name>, <name><surname>Biswas</surname><given-names>A</given-names></name>, <name><surname>Kobayashi</surname><given-names>KS</given-names></name>. <article-title>MyD88-dependent signaling contributes to host defense against ehrlichial infection</article-title>. <source>PLoS One</source>. <year>2010</year>;<volume>5</volume>(<issue>7</issue>):<fpage>e11758</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0011758">10.1371/journal.pone.0011758</ext-link></comment>
<?supplied-pmid 20668698?><pub-id pub-id-type="pmid">20668698</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Rikihisa</surname><given-names>Y</given-names></name>. <article-title>Molecular pathogenesis of <italic>Ehrlichia chaffeensis</italic> infection</article-title>. <source>Annu Rev Microbiol</source>. <year>2015</year>;<volume>69</volume>:<fpage>283</fpage>&#x02013;<lpage>304</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1146/annurev-micro-091014-104411">10.1146/annurev-micro-091014-104411</ext-link></comment>
<?supplied-pmid 26488275?><pub-id pub-id-type="pmid">26488275</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Severo</surname><given-names>MS</given-names></name>, <name><surname>Stephens</surname><given-names>KD</given-names></name>, <name><surname>Kotsyfakis</surname><given-names>M</given-names></name>, <name><surname>Pedra</surname><given-names>JH</given-names></name>. <article-title><italic>Anaplasma phagocytophilum</italic>: deceptively simple or simply deceptive?</article-title>
<source>Future Microbiol</source>. <year>2012</year>;<volume>7</volume>(<issue>6</issue>):<fpage>719</fpage>&#x02013;<lpage>31</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2217/fmb.12.45">10.2217/fmb.12.45</ext-link></comment>
<?supplied-pmid 22702526?><pub-id pub-id-type="pmid">22702526</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Ge</surname><given-names>Y</given-names></name>, <name><surname>Rikihisa</surname><given-names>Y</given-names></name>. <article-title>Subversion of host cell signaling by <italic>Orientia tsutsugamushi</italic></article-title>. <source>Microbes Infect</source>. <year>2011</year>;<volume>13</volume>(<issue>7</issue>):<fpage>638</fpage>&#x02013;<lpage>48</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.micinf.2011.03.003">10.1016/j.micinf.2011.03.003</ext-link></comment>
<?supplied-pmid 21458586?><pub-id pub-id-type="pmid">21458586</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Dunning Hotopp</surname><given-names>JC</given-names></name>, <name><surname>Lin</surname><given-names>M</given-names></name>, <name><surname>Madupu</surname><given-names>R</given-names></name>, <name><surname>Crabtree</surname><given-names>J</given-names></name>, <name><surname>Angiuoli</surname><given-names>SV</given-names></name>, <name><surname>Eisen</surname><given-names>JA</given-names></name>, <etal>et al</etal>
<article-title>Comparative genomics of emerging human ehrlichiosis agents</article-title>. <source>PLoS Genet</source>. <year>2006</year>;<volume>2</volume>(<issue>2</issue>):<fpage>e21</fpage>
<?supplied-pmid 16482227?><pub-id pub-id-type="pmid">16482227</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Amano</surname><given-names>K</given-names></name>, <name><surname>Tamura</surname><given-names>A</given-names></name>, <name><surname>Ohashi</surname><given-names>N</given-names></name>, <name><surname>Urakami</surname><given-names>H</given-names></name>, <name><surname>Kaya</surname><given-names>S</given-names></name>, <name><surname>Fukushi</surname><given-names>K</given-names></name>. <article-title>Deficiency of peptidoglycan and lipopolysaccharide components in <italic>Rickettsia tsutsugamushi</italic></article-title>. <source>Infect Immun</source>. <year>1987</year>;<volume>55</volume>(<issue>9</issue>):<fpage>2290</fpage>&#x02013;<lpage>2</lpage>. <?supplied-pmid 3114150?><pub-id pub-id-type="pmid">3114150</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Ting</surname><given-names>JP</given-names></name>, <name><surname>Duncan</surname><given-names>JA</given-names></name>, <name><surname>Lei</surname><given-names>Y</given-names></name>. <article-title>How the noninflammasome NLRs function in the innate immune system</article-title>. <source>Science</source>. <year>2010</year>;<volume>327</volume>(<issue>5963</issue>):<fpage>286</fpage>&#x02013;<lpage>90</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.1184004">10.1126/science.1184004</ext-link></comment>
<?supplied-pmid 20075243?><pub-id pub-id-type="pmid">20075243</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Sukumaran</surname><given-names>B</given-names></name>, <name><surname>Ogura</surname><given-names>Y</given-names></name>, <name><surname>Pedra</surname><given-names>JH</given-names></name>, <name><surname>Kobayashi</surname><given-names>KS</given-names></name>, <name><surname>Flavell</surname><given-names>RA</given-names></name>, <name><surname>Fikrig</surname><given-names>E</given-names></name>. <article-title>Receptor interacting protein-2 contributes to host defense against <italic>Anaplasma phagocytophilum</italic> infection</article-title>. <source>FEMS Immunol Med Microbiol</source>. <year>2012</year>;<volume>66</volume>(<issue>2</issue>):<fpage>211</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1574-695X.2012.01001.x">10.1111/j.1574-695X.2012.01001.x</ext-link></comment>
<?supplied-pmid 22747758?><pub-id pub-id-type="pmid">22747758</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Cho</surname><given-names>KA</given-names></name>, <name><surname>Jun</surname><given-names>YH</given-names></name>, <name><surname>Suh</surname><given-names>JW</given-names></name>, <name><surname>Kang</surname><given-names>JS</given-names></name>, <name><surname>Choi</surname><given-names>HJ</given-names></name>, <name><surname>Woo</surname><given-names>SY</given-names></name>. <article-title><italic>Orientia tsutsugamushi</italic> induced endothelial cell activation via the NOD1-IL-32 pathway</article-title>. <source>Microb Pathog</source>. <year>2010</year>;<volume>49</volume>(<issue>3</issue>):<fpage>95</fpage>&#x02013;<lpage>104</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.micpath.2010.05.001">10.1016/j.micpath.2010.05.001</ext-link></comment>
<?supplied-pmid 20470879?><pub-id pub-id-type="pmid">20470879</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Guo</surname><given-names>H</given-names></name>, <name><surname>Callaway</surname><given-names>JB</given-names></name>, <name><surname>Ting</surname><given-names>JP</given-names></name>. <article-title>Inflammasomes: mechanism of action, role in disease, and therapeutics</article-title>. <source>Nat Med</source>. <year>2015</year>.</mixed-citation></ref><ref id="ppat.1005803.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>Q</given-names></name>, <name><surname>Stevenson</surname><given-names>HL</given-names></name>, <name><surname>Scott</surname><given-names>MJ</given-names></name>, <name><surname>Ismail</surname><given-names>N</given-names></name>. <article-title>Type I interferon contributes to noncanonical inflammasome activation, mediates immunopathology, and impairs protective immunity during fatal infection with lipopolysaccharide-negative ehrlichiae</article-title>. <source>Am J Pathol</source>. <year>2015</year>;<volume>185</volume>(<issue>2</issue>):<fpage>446</fpage>&#x02013;<lpage>61</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ajpath.2014.10.005">10.1016/j.ajpath.2014.10.005</ext-link></comment>
<?supplied-pmid 25481711?><pub-id pub-id-type="pmid">25481711</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Kofoed</surname><given-names>EM</given-names></name>, <name><surname>Vance</surname><given-names>RE</given-names></name>. <article-title>Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity</article-title>. <source>Nature</source>. <year>2011</year>;<volume>477</volume>(<issue>7366</issue>):<fpage>592</fpage>&#x02013;<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature10394">10.1038/nature10394</ext-link></comment>
<?supplied-pmid 21874021?><pub-id pub-id-type="pmid">21874021</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>Y</given-names></name>, <name><surname>Yang</surname><given-names>J</given-names></name>, <name><surname>Shi</surname><given-names>J</given-names></name>, <name><surname>Gong</surname><given-names>YN</given-names></name>, <name><surname>Lu</surname><given-names>Q</given-names></name>, <name><surname>Xu</surname><given-names>H</given-names></name>, <etal>et al</etal>
<article-title>The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus</article-title>. <source>Nature</source>. <year>2011</year>;<volume>477</volume>(<issue>7366</issue>):<fpage>596</fpage>&#x02013;<lpage>600</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature10510">10.1038/nature10510</ext-link></comment>
<?supplied-pmid 21918512?><pub-id pub-id-type="pmid">21918512</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Hu</surname><given-names>Z</given-names></name>, <name><surname>Zhou</surname><given-names>Q</given-names></name>, <name><surname>Zhang</surname><given-names>C</given-names></name>, <name><surname>Fan</surname><given-names>S</given-names></name>, <name><surname>Cheng</surname><given-names>W</given-names></name>, <name><surname>Zhao</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Structural and biochemical basis for induced self-propagation of NLRC4</article-title>. <source>Science</source>. <year>2015</year>;<volume>350</volume>(<issue>6259</issue>):<fpage>399</fpage>&#x02013;<lpage>404</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.aac5489">10.1126/science.aac5489</ext-link></comment>
<?supplied-pmid 26449475?><pub-id pub-id-type="pmid">26449475</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>L</given-names></name>, <name><surname>Chen</surname><given-names>S</given-names></name>, <name><surname>Ruan</surname><given-names>J</given-names></name>, <name><surname>Wu</surname><given-names>J</given-names></name>, <name><surname>Tong</surname><given-names>AB</given-names></name>, <name><surname>Yin</surname><given-names>Q</given-names></name>, <etal>et al</etal>
<article-title>Cryo-EM structure of the activated NAIP2-NLRC4 inflammasome reveals nucleated polymerization</article-title>. <source>Science</source>. <year>2015</year>;<volume>350</volume>(<issue>6259</issue>):<fpage>404</fpage>&#x02013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.aac5789">10.1126/science.aac5789</ext-link></comment>
<?supplied-pmid 26449474?><pub-id pub-id-type="pmid">26449474</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Diebolder</surname><given-names>CA</given-names></name>, <name><surname>Halff</surname><given-names>EF</given-names></name>, <name><surname>Koster</surname><given-names>AJ</given-names></name>, <name><surname>Huizinga</surname><given-names>EG</given-names></name>, <name><surname>Koning</surname><given-names>RI</given-names></name>. <article-title>Cryoelectron tomography of the NAIP5/NLRC4 inflammasome: implications for NLR activation</article-title>. <source>Structure</source>. <year>2015</year>;<volume>23</volume>(<issue>12</issue>):<fpage>2349</fpage>&#x02013;<lpage>57</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.str.2015.10.001">10.1016/j.str.2015.10.001</ext-link></comment>
<?supplied-pmid 26585513?><pub-id pub-id-type="pmid">26585513</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>Y</given-names></name>, <name><surname>Shi</surname><given-names>J</given-names></name>, <name><surname>Shi</surname><given-names>X</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>F</given-names></name>, <name><surname>Shao</surname><given-names>F</given-names></name>. <article-title>Genetic functions of the NAIP family of inflammasome receptors for bacterial ligands in mice</article-title>. <source>J Exp Med</source>. <year>2016</year>;<volume>213</volume>(<issue>5</issue>):<fpage>647</fpage>&#x02013;<lpage>56</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1084/jem.20160006">10.1084/jem.20160006</ext-link></comment>
<?supplied-pmid 27114610?><pub-id pub-id-type="pmid">27114610</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Rauch</surname><given-names>I</given-names></name>, <name><surname>Tenthorey</surname><given-names>JL</given-names></name>, <name><surname>Nichols</surname><given-names>RD</given-names></name>, <name><surname>Al Moussawi</surname><given-names>K</given-names></name>, <name><surname>Kang</surname><given-names>JJ</given-names></name>, <name><surname>Kang</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>NAIP proteins are required for cytosolic detection of specific bacterial ligands <italic>in vivo</italic></article-title>. <source>J Exp Med</source>. <year>2016</year>;<volume>213</volume>(<issue>5</issue>):<fpage>657</fpage>&#x02013;<lpage>65</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1084/jem.20151809">10.1084/jem.20151809</ext-link></comment>
<?supplied-pmid 27045008?><pub-id pub-id-type="pmid">27045008</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Pedra</surname><given-names>JH</given-names></name>, <name><surname>Sutterwala</surname><given-names>FS</given-names></name>, <name><surname>Sukumaran</surname><given-names>B</given-names></name>, <name><surname>Ogura</surname><given-names>Y</given-names></name>, <name><surname>Qian</surname><given-names>F</given-names></name>, <name><surname>Montgomery</surname><given-names>RR</given-names></name>, <etal>et al</etal>
<article-title>ASC/PYCARD and caspase-1 regulate the IL-18/IFN-&#x003b3; axis during <italic>Anaplasma phagocytophilum</italic> infection</article-title>. <source>J Immunol</source>. <year>2007</year>;<volume>179</volume>(<issue>7</issue>):<fpage>4783</fpage>&#x02013;<lpage>91</lpage>. <?supplied-pmid 17878377?><pub-id pub-id-type="pmid">17878377</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Rikihisa</surname><given-names>Y</given-names></name>, <name><surname>Lin</surname><given-names>M</given-names></name>, <name><surname>Niu</surname><given-names>H</given-names></name>. <article-title>Type IV secretion in the obligatory intracellular bacterium Anaplasma phagocytophilum</article-title>. <source>Cell Microbiol</source>. <year>2010</year>;<volume>12</volume>(<issue>9</issue>):<fpage>1213</fpage>&#x02013;<lpage>21</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1462-5822.2010.01500.x">10.1111/j.1462-5822.2010.01500.x</ext-link></comment>
<?supplied-pmid 20670295?><pub-id pub-id-type="pmid">20670295</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>G</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Severo</surname><given-names>MS</given-names></name>, <name><surname>Sakhon</surname><given-names>OS</given-names></name>, <name><surname>Sohail</surname><given-names>M</given-names></name>, <name><surname>Brown</surname><given-names>LJ</given-names></name>, <etal>et al</etal>
<article-title>The tick salivary protein Sialostatin L2 inhibits caspase-1-mediated inflammation during <italic>Anaplasma phagocytophilum</italic> infection</article-title>. <source>Infect Immun</source>. <year>2014</year>; <volume>82</volume>(<issue>6</issue>):<fpage>2553</fpage>&#x02013;<lpage>64</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/IAI.01679-14">10.1128/IAI.01679-14</ext-link></comment>
<?supplied-pmid 24686067?><pub-id pub-id-type="pmid">24686067</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Shaw</surname><given-names>DK</given-names></name>, <name><surname>Sakhon</surname><given-names>OS</given-names></name>, <name><surname>Snyder</surname><given-names>GA</given-names></name>, <name><surname>Sundberg</surname><given-names>EJ</given-names></name>, <name><surname>Santambrogio</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>The tick protein Sialostatin L2 binds to Annexin A2 and inhibits NLRC4-mediated inflammasome activation</article-title>. <source>Infect Immun</source>. <year>2016</year>;<volume>84</volume>(<issue>6</issue>):<fpage>1796</fpage>&#x02013;<lpage>805</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/IAI.01526-15">10.1128/IAI.01526-15</ext-link></comment>
<?supplied-pmid 27045038?><pub-id pub-id-type="pmid">27045038</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Trebino</surname><given-names>CE</given-names></name>, <name><surname>Stock</surname><given-names>JL</given-names></name>, <name><surname>Gibbons</surname><given-names>CP</given-names></name>, <name><surname>Naiman</surname><given-names>BM</given-names></name>, <name><surname>Wachtmann</surname><given-names>TS</given-names></name>, <name><surname>Umland</surname><given-names>JP</given-names></name>, <etal>et al</etal>
<article-title>Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2003</year>;<volume>100</volume>(<issue>15</issue>):<fpage>9044</fpage>&#x02013;<lpage>9</lpage>. <?supplied-pmid 12835414?><pub-id pub-id-type="pmid">12835414</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Kawahara</surname><given-names>K</given-names></name>, <name><surname>Hohjoh</surname><given-names>H</given-names></name>, <name><surname>Inazumi</surname><given-names>T</given-names></name>, <name><surname>Tsuchiya</surname><given-names>S</given-names></name>, <name><surname>Sugimoto</surname><given-names>Y</given-names></name>. <article-title>Prostaglandin E<sub>2</sub>-induced inflammation: Relevance of prostaglandin E receptors</article-title>. <source>Biochim Biophys Acta</source>. <year>2015</year>; <volume>1851</volume>(<issue>4</issue>):<fpage>414</fpage>&#x02013;<lpage>21</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.bbalip.2014.07.008">10.1016/j.bbalip.2014.07.008</ext-link></comment>
<?supplied-pmid 25038274?><pub-id pub-id-type="pmid">25038274</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Dumler</surname><given-names>JS</given-names></name>, <name><surname>Barat</surname><given-names>NC</given-names></name>, <name><surname>Barat</surname><given-names>CE</given-names></name>, <name><surname>Bakken</surname><given-names>JS</given-names></name>. <article-title>Human granulocytic anaplasmosis and macrophage activation</article-title>. <source>Clin Infect Dis</source>. <year>2007</year>;<volume>45</volume>(<issue>2</issue>):<fpage>199</fpage>&#x02013;<lpage>204</lpage>. <?supplied-pmid 17578779?><pub-id pub-id-type="pmid">17578779</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Dumler</surname><given-names>JS</given-names></name>. <article-title>The biological basis of severe outcomes in <italic>Anaplasma phagocytophilum</italic> infection</article-title>. <source>FEMS Immunol Med Microbiol</source>. <year>2012</year>;<volume>64</volume>(<issue>1</issue>):<fpage>13</fpage>&#x02013;<lpage>20</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1574-695X.2011.00909.x">10.1111/j.1574-695X.2011.00909.x</ext-link></comment>
<?supplied-pmid 22098465?><pub-id pub-id-type="pmid">22098465</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Lepidi</surname><given-names>H</given-names></name>, <name><surname>Bunnell</surname><given-names>JE</given-names></name>, <name><surname>Martin</surname><given-names>ME</given-names></name>, <name><surname>Madigan</surname><given-names>JE</given-names></name>, <name><surname>Stuen</surname><given-names>S</given-names></name>, <name><surname>Dumler</surname><given-names>JS</given-names></name>. <article-title>Comparative pathology, and immunohistology associated with clinical illness after <italic>Ehrlichia phagocytophila</italic>-group infections</article-title>. <source>Am J Trop Med Hyg</source>. <year>2000</year>;<volume>62</volume>(<issue>1</issue>):<fpage>29</fpage>&#x02013;<lpage>37</lpage>. <?supplied-pmid 10761721?><pub-id pub-id-type="pmid">10761721</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Choi</surname><given-names>KS</given-names></name>, <name><surname>Scorpio</surname><given-names>DG</given-names></name>, <name><surname>Dumler</surname><given-names>JS</given-names></name>. <article-title><italic>Anaplasma phagocytophilum</italic> ligation to toll-like receptor (TLR) 2, but not to TLR4, activates macrophages for nuclear factor-kappa B translocation</article-title>. <source>J Infect Dis</source>. <year>2004</year>;<volume>189</volume>(<issue>10</issue>):<fpage>1921</fpage>&#x02013;<lpage>5</lpage>. <?supplied-pmid 15122530?><pub-id pub-id-type="pmid">15122530</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Dennis</surname><given-names>EA</given-names></name>, <name><surname>Norris</surname><given-names>PC</given-names></name>. <article-title>Eicosanoid storm in infection and inflammation</article-title>. <source>Nat Rev Immunol</source>. <year>2015</year>; <volume>15</volume>(<issue>8</issue>):<fpage>511</fpage>&#x02013;<lpage>23</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nri3859">10.1038/nri3859</ext-link></comment>
<?supplied-pmid 26139350?><pub-id pub-id-type="pmid">26139350</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>von Moltke</surname><given-names>J</given-names></name>, <name><surname>Trinidad</surname><given-names>NJ</given-names></name>, <name><surname>Moayeri</surname><given-names>M</given-names></name>, <name><surname>Kintzer</surname><given-names>AF</given-names></name>, <name><surname>Wang</surname><given-names>SB</given-names></name>, <name><surname>van Rooijen</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>Rapid induction of inflammatory lipid mediators by the inflammasome <italic>in vivo</italic></article-title>. <source>Nature</source>. <year>2012</year>;<volume>490</volume>(<issue>7418</issue>):<fpage>107</fpage>&#x02013;<lpage>11</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature11351">10.1038/nature11351</ext-link></comment>
<?supplied-pmid 22902502?><pub-id pub-id-type="pmid">22902502</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Shirey</surname><given-names>KA</given-names></name>, <name><surname>Lai</surname><given-names>W</given-names></name>, <name><surname>Pletneva</surname><given-names>LM</given-names></name>, <name><surname>Karp</surname><given-names>CL</given-names></name>, <name><surname>Divanovic</surname><given-names>S</given-names></name>, <name><surname>Blanco</surname><given-names>JC</given-names></name>, <etal>et al</etal>
<article-title>Role of the lipoxygenase pathway in RSV-induced alternatively activated macrophages leading to resolution of lung pathology</article-title>. <source>Mucosal Immunol</source>. <year>2014</year>;<volume>7</volume>(<issue>3</issue>):<fpage>549</fpage>&#x02013;<lpage>57</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/mi.2013.71">10.1038/mi.2013.71</ext-link></comment>
<?supplied-pmid 24064666?><pub-id pub-id-type="pmid">24064666</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Simmons</surname><given-names>DL</given-names></name>, <name><surname>Botting</surname><given-names>RM</given-names></name>, <name><surname>Hla</surname><given-names>T</given-names></name>. <article-title>Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition</article-title>. <source>Pharmacol Rev</source>. <year>2004</year>;<volume>56</volume>(<issue>3</issue>):<fpage>387</fpage>&#x02013;<lpage>437</lpage>. <?supplied-pmid 15317910?><pub-id pub-id-type="pmid">15317910</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Truchan</surname><given-names>HK</given-names></name>, <name><surname>Cockburn</surname><given-names>CL</given-names></name>, <name><surname>Hebert</surname><given-names>KS</given-names></name>, <name><surname>Magunda</surname><given-names>F</given-names></name>, <name><surname>Noh</surname><given-names>SM</given-names></name>, <name><surname>Carlyon</surname><given-names>JA</given-names></name>. <article-title>The pathogen-occupied vacuoles of <italic>Anaplasma phagocytophilum</italic> and <italic>Anaplasma marginale</italic> interact with the endoplasmic reticulum</article-title>. <source>Front Cell Infect Microbiol</source>. <year>2016</year>;<volume>6</volume>:<fpage>22</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3389/fcimb.2016.00022">10.3389/fcimb.2016.00022</ext-link></comment>
<?supplied-pmid 26973816?><pub-id pub-id-type="pmid">26973816</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Keestra-Gounder</surname><given-names>AM</given-names></name>, <name><surname>Byndloss</surname><given-names>MX</given-names></name>, <name><surname>Seyffert</surname><given-names>N</given-names></name>, <name><surname>Young</surname><given-names>BM</given-names></name>, <name><surname>Chavez-Arroyo</surname><given-names>A</given-names></name>, <name><surname>Tsai</surname><given-names>AY</given-names></name>, <etal>et al</etal>
<article-title>NOD1 and NOD2 signalling links ER stress with inflammation</article-title>. <source>Nature</source>. <year>2016</year>;<volume>532</volume>(<issue>7599</issue>):<fpage>394</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature17631">10.1038/nature17631</ext-link></comment>
<?supplied-pmid 27007849?><pub-id pub-id-type="pmid">27007849</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Taxman</surname><given-names>DJ</given-names></name>, <name><surname>Lei</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>S</given-names></name>, <name><surname>Holley-Guthrie</surname><given-names>E</given-names></name>, <name><surname>Offenbacher</surname><given-names>S</given-names></name>, <name><surname>Ting</surname><given-names>JP</given-names></name>. <article-title>ASC-dependent RIP2 kinase regulates reduced PGE<sub>2</sub> production in chronic periodontitis</article-title>. <source>J Dent Res</source>. <year>2012</year>;<volume>91</volume>(<issue>9</issue>):<fpage>877</fpage>&#x02013;<lpage>82</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1177/0022034512454541">10.1177/0022034512454541</ext-link></comment>
<?supplied-pmid 22828789?><pub-id pub-id-type="pmid">22828789</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Tsuchiya</surname><given-names>H</given-names></name>, <name><surname>Oka</surname><given-names>T</given-names></name>, <name><surname>Nakamura</surname><given-names>K</given-names></name>, <name><surname>Ichikawa</surname><given-names>A</given-names></name>, <name><surname>Saper</surname><given-names>CB</given-names></name>, <name><surname>Sugimoto</surname><given-names>Y</given-names></name>. <article-title>Prostaglandin E<sub>2</sub> attenuates preoptic expression of GABAA receptors via EP3 receptors</article-title>. <source>J Biol Chem</source>. <year>2008</year>;<volume>283</volume>(<issue>16</issue>):<fpage>11064</fpage>&#x02013;<lpage>71</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M801359200">10.1074/jbc.M801359200</ext-link></comment>
<?supplied-pmid 18292084?><pub-id pub-id-type="pmid">18292084</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Pizza</surname><given-names>M</given-names></name>, <name><surname>Covacci</surname><given-names>A</given-names></name>, <name><surname>Bartoloni</surname><given-names>A</given-names></name>, <name><surname>Perugini</surname><given-names>M</given-names></name>, <name><surname>Nencioni</surname><given-names>L</given-names></name>, <name><surname>De Magistris</surname><given-names>MT</given-names></name>, <etal>et al</etal>
<article-title>Mutants of pertussis toxin suitable for vaccine development</article-title>. <source>Science</source>. <year>1989</year>;<volume>246</volume>(<issue>4929</issue>):<fpage>497</fpage>&#x02013;<lpage>500</lpage>. <?supplied-pmid 2683073?><pub-id pub-id-type="pmid">2683073</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Morimoto</surname><given-names>K</given-names></name>, <name><surname>Shirata</surname><given-names>N</given-names></name>, <name><surname>Taketomi</surname><given-names>Y</given-names></name>, <name><surname>Tsuchiya</surname><given-names>S</given-names></name>, <name><surname>Segi-Nishida</surname><given-names>E</given-names></name>, <name><surname>Inazumi</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Prostaglandin E<sub>2</sub>-EP3 signaling induces inflammatory swelling by mast cell activation</article-title>. <source>J Immunol</source>. <year>2014</year>;<volume>192</volume>(<issue>3</issue>):<fpage>1130</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4049/jimmunol.1300290">10.4049/jimmunol.1300290</ext-link></comment>
<?supplied-pmid 24342806?><pub-id pub-id-type="pmid">24342806</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Sokolowska</surname><given-names>M</given-names></name>, <name><surname>Chen</surname><given-names>LY</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Martinez-Anton</surname><given-names>A</given-names></name>, <name><surname>Qi</surname><given-names>HY</given-names></name>, <name><surname>Logun</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Prostaglandin E<sub>2</sub> inhibits NLRP3 inflammasome activation through EP4 Receptor and intracellular cyclic AMP in human macrophages</article-title>. <source>J Immunol</source>. <year>2015</year>;<volume>194</volume>(<issue>11</issue>):<fpage>5472</fpage>&#x02013;<lpage>87</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4049/jimmunol.1401343">10.4049/jimmunol.1401343</ext-link></comment>
<?supplied-pmid 25917098?><pub-id pub-id-type="pmid">25917098</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Ceddia</surname><given-names>RP</given-names></name>, <name><surname>Lee</surname><given-names>D</given-names></name>, <name><surname>Maulis</surname><given-names>MF</given-names></name>, <name><surname>Carboneau</surname><given-names>BA</given-names></name>, <name><surname>Threadgill</surname><given-names>DW</given-names></name>, <name><surname>Poffenberger</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>The PGE<sub>2</sub> EP3 receptor regulates diet-induced adiposity in male mice</article-title>. <source>Endocrinology</source>. <year>2016</year>;<volume>157</volume>(<issue>1</issue>):<fpage>220</fpage>&#x02013;<lpage>32</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1210/en.2015-1693">10.1210/en.2015-1693</ext-link></comment>
<?supplied-pmid 26485614?><pub-id pub-id-type="pmid">26485614</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref047"><label>47</label><mixed-citation publication-type="journal"><name><surname>Perkins</surname><given-names>DJ</given-names></name>, <name><surname>Polumuri</surname><given-names>SK</given-names></name>, <name><surname>Pennini</surname><given-names>ME</given-names></name>, <name><surname>Lai</surname><given-names>W</given-names></name>, <name><surname>Xie</surname><given-names>P</given-names></name>, <name><surname>Vogel</surname><given-names>SN</given-names></name>. <article-title>Reprogramming of murine macrophages through TLR2 confers viral resistance via TRAF3-mediated, enhanced interferon production</article-title>. <source>PLoS Pathog</source>. <year>2013</year>;<volume>9</volume>(<issue>7</issue>):<fpage>e1003479</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.1003479">10.1371/journal.ppat.1003479</ext-link></comment>
<?supplied-pmid 23853595?><pub-id pub-id-type="pmid">23853595</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref048"><label>48</label><mixed-citation publication-type="journal"><name><surname>Bonventre</surname><given-names>JV</given-names></name>, <name><surname>Huang</surname><given-names>Z</given-names></name>, <name><surname>Taheri</surname><given-names>MR</given-names></name>, <name><surname>O'Leary</surname><given-names>E</given-names></name>, <name><surname>Li</surname><given-names>E</given-names></name>, <name><surname>Moskowitz</surname><given-names>MA</given-names></name>, <etal>et al</etal>
<article-title>Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2</article-title>. <source>Nature</source>. <year>1997</year>;<volume>390</volume>(<issue>6660</issue>):<fpage>622</fpage>&#x02013;<lpage>5</lpage>. <?supplied-pmid 9403693?><pub-id pub-id-type="pmid">9403693</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref049"><label>49</label><mixed-citation publication-type="journal"><name><surname>Tennant</surname><given-names>SM</given-names></name>, <name><surname>Wang</surname><given-names>JY</given-names></name>, <name><surname>Galen</surname><given-names>JE</given-names></name>, <name><surname>Simon</surname><given-names>R</given-names></name>, <name><surname>Pasetti</surname><given-names>MF</given-names></name>, <name><surname>Gat</surname><given-names>O</given-names></name>, <etal>et al</etal>
<article-title>Engineering and preclinical evaluation of attenuated nontyphoidal <italic>Salmonella</italic> strains serving as live oral vaccines and as reagent strains</article-title>. <source>Infect Immun</source>. <year>2011</year>;<volume>79</volume>(<issue>10</issue>):<fpage>4175</fpage>&#x02013;<lpage>85</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/IAI.05278-11">10.1128/IAI.05278-11</ext-link></comment>
<?supplied-pmid 21807911?><pub-id pub-id-type="pmid">21807911</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref050"><label>50</label><mixed-citation publication-type="journal"><name><surname>Carbonetti</surname><given-names>NH</given-names></name>, <name><surname>Artamonova</surname><given-names>GV</given-names></name>, <name><surname>Mays</surname><given-names>RM</given-names></name>, <name><surname>Worthington</surname><given-names>ZE</given-names></name>. <article-title>Pertussis toxin plays an early role in respiratory tract colonization by <italic>Bordetella pertussis</italic></article-title>. <source>Infect Immun</source>. <year>2003</year>;<volume>71</volume>(<issue>11</issue>):<fpage>6358</fpage>&#x02013;<lpage>66</lpage>. <?supplied-pmid 14573656?><pub-id pub-id-type="pmid">14573656</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref051"><label>51</label><mixed-citation publication-type="journal"><name><surname>Ijdo</surname><given-names>JW</given-names></name>, <name><surname>Sun</surname><given-names>W</given-names></name>, <name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Magnarelli</surname><given-names>LA</given-names></name>, <name><surname>Fikrig</surname><given-names>E</given-names></name>. <article-title>Cloning of the gene encoding the 44-kilodalton antigen of the agent of human granulocytic ehrlichiosis and characterization of the humoral response</article-title>. <source>Infect Immun</source>. <year>1998</year>;<volume>66</volume>(<issue>7</issue>):<fpage>3264</fpage>&#x02013;<lpage>9</lpage>. <?supplied-pmid 9632594?><pub-id pub-id-type="pmid">9632594</pub-id></mixed-citation></ref><ref id="ppat.1005803.ref052"><label>52</label><mixed-citation publication-type="journal"><name><surname>Lucas</surname><given-names>KK</given-names></name>, <name><surname>Dennis</surname><given-names>EA</given-names></name>. <article-title>The ABC's of group IV cytosolic phospholipase A2</article-title>. <source>Biochim Biophys Acta</source>. <year>2004</year>;<volume>1636</volume>(<issue>2&#x02013;3</issue>):<fpage>213</fpage>&#x02013;<lpage>8</lpage>. <?supplied-pmid 15164769?><pub-id pub-id-type="pmid">15164769</pub-id></mixed-citation></ref></ref-list></back></article>